1. Introduction {#sec1}
===============

Four diseases account for the majority of bacterial respiratory infections globally. Of these, tuberculosis (caused by *Mycobacterium tuberculosis*) has the greatest burden and is classified as one of the top ten causes of death globally ([@bib27]). This disease is highly contagious and is readily spread via airborne transmission. Indeed, the World Health Organisation (WHO) estimates that more than 10 million people fell ill with tuberculosis in 2018, with 1.5 million people dying from the disease ([@bib81]). Of the people contracting *M. tuberculosis* infections, only 10% develop the active form of the disease and fall ill ([@bib32]). Therefore, it is estimated that a pool of 100 million new potentially infective people contracted *M. tuberculosis* infections in 2018. Bacterial pneumonia is also a considerable cause of mortality and morbidity. Indeed, it is classed as the second highest cause of mortality of any communicable disease (after tuberculosis), with more than 800,000 deaths estimated in 2017 ([@bib85]). Diphtheria and pertussis caused similarly high mortality rates prior to the widespread introduction of effective vaccination ([@bib31]). Vaccines have been particularly effective and the rates of infection and mortality have decreased dramatically. For example, the number of reported cases of diphtheria decreased from \>1 million cases in 1980 to approximately 4500 in 2018 ([@bib82]; [@bib31]). Similar trends for the incidence of pertussis have been reported although it still causes a considerable health burden, with 150,000 new cases and 90,000 deaths reported in 2018 ([@bib83]; ([@bib31]). This review concentrates on the use of southern African plants to treat these four diseases due to their relevance to southern African health. Whilst other bacteria such as *Legionella pneumophila* (Legionaires disease) may also cause respiratory diseases, they make relatively minor contributions to southern African health ([@bib54]) and thus are not a focus of this review.

1.1. Tuberculosis {#sec1.1}
-----------------

Tuberculosis (TB) is the most serious of the bacterial respiratory infections globally ([@bib27]). It is classified by the World Health Organisation (WHO) as one of the top ten causes of death globally, and the leading cause of death by a single pathogen, ranking substantially ahead of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) ([@bib81]). TB has a high infection rate due to its air-borne route of transmission. When an infected person coughs or sneezes (or even talks), small droplets of saliva containing the bacterium are released and dispersed into the air. If other individuals breathe in these droplets, they may also become infected. The spread from person to person is rapid and there is a high infection rate. Indeed, the WHO estimates that approximately a quarter of the world\'s population is infected with *M. tuberculosis* at any given time and thus at risk of developing TB ([@bib81]; [@bib27]). These high rates of infection also increase the risks of infection to non-infected members of the population.

Tuberculosis generally affects the lungs, although it can also infect other parts of the body. Most infections are asymptomatic and are known as latent TB. People with latent TB do not suffer from the disease\'s symptoms, nor do they generally spread the disease ([@bib28]). However, they have the potential to spread the bacterium if the disease progresses and therefore they constitute a substantial potential disease reservoir. However, active TB infections are substantially more frequent in immune-compromised individuals, such as people with HIV/AIDS ([@bib63]). When active TB develops, there is a high mortality rate, with approximately 50% of afflicted individuals dying unless they receive timely and effective medical treatment ([@bib27]).

A number of symptoms are evident in people with TB: chronic coughing with blood containing sputum, fever, night sweats and rapid weight loss (which is responsible for the historical name 'consumption') ([@bib28]). Medical intervention for TB most frequently involves vaccination and \>90% of children are vaccinated globally. The efficacy of the vaccine is low, decreasing the risk of acquiring a *M. tuberculosis* by only 20%. However, once an infection occurs, the vaccination decreases the chances that the infection will develop from a latent to active form of TB by 60%. If active TB develops, treatment with antibiotics for 6--9 months is often effective in curing the disease and blocking the transmission from the infected person to others ([@bib59]). However, limited classes of antibiotics are effective against *M. tuberculosis* as the cell wall blocks cell entry for most antibiotic classes. A combination of rifampicin, isoniazid, pyrazinamide and [ethambutol](https://en.wikipedia.org/wiki/Ethambutol){#intref0010} is generally used to increase the efficacy of the treatment ([@bib28]). Of considerable concern, there are increasing reports of *M. tuberculosis* strains with resistance to these antibiotics, rendering these combinations of little use ([@bib59]). Effective new antibiotic therapies are urgently required to treat these resistant strains.

1.2. Diphtheria {#sec1.2}
---------------

Diphtheria is another bacterial infection that can cause substantial mortality. Indeed, 5--10% of infections result in death, although the mortality rate can be as high as 20% in children less than 5 years of age and in adults over 40 years old ([@bib82]; [@bib31]). Outbreaks are rare in developed countries due to medical advances, although they are more common in developing populations. Diphtheria primarily affects the upper respiratory tract, causing symptoms that range from mild to severe ([@bib74]). The disease is caused by the bacterium *Cornyebacterium diphtheria* and is transmitted in a similar way to TB: from person to person via air-borne pathways. Once a person breathes in the bacterium, disease progression is rapid, with symptoms usually evident within 2--5 days after exposure. The symptoms may include a sore throat, fever, chills, fatigue, cyanosis, coughs, headaches, difficulty swallowing and swollen lymph nodes, resulting in swelling of the neck. Grey or white pseudo-membrane patches may also develop in the throat of infected people, restricting the airways and causing a 'barking' cough similar to that seen for croup. In severe cases, myocarditis, nerve inflammation, renal disease and decreased blood clotting (due to low platelet levels) may also occur.

The widespread usage of an effective vaccine has substantially reduced the incidence of diphtheria globally ([@bib82]; [@bib31]). This vaccine is now routinely given to children (in conjunction with whooping cough and tetanus vaccines) as a three or four dose regimen. Immunity is not life-long and repeated vaccinations are recommended every ten years after the initial vaccination. The diphtheria vaccination is generally quite effective and has greatly reduced the incidence of the disease since its widespread introduction. Indeed, the WHO estimates that approximately 4500 cases of diphtheria are now reported each year, down from \>1 million cases a year prior to 1980 ([@bib82]; [@bib31]). When *C. diphtheriae* infections occur (generally in non-vaccinated people in developing countries), antibiotic therapy may be effective in curing the disease and blocking its further spread. Metronidazole, erythromycin, penicillin-G, rifamin or clindamycin are most frequently used to treat diphtheria ([@bib74]). However, multi-antibiotic resistant *C. diphtheriae* strains are increasingly being reported ([@bib26]; [@bib52]) and new antibiotic therapies are required.

1.3. Pertussis (whooping cough) {#sec1.3}
-------------------------------

Pertussis (commonly known as whooping cough) is a highly contagious bacterial disease that infects large numbers of people annually despite the availability of an effective vaccine ([@bib31]). Indeed, the WHO estimated that over 150,000 new cases were reported in 2018, with nearly 90,000 deaths ([@bib83]). However, not all cases are reported, particularly in developing countries, and it is likely that the WHO estimate substantially understates the prevalence of this disease. Indeed, other studies have estimated that there were 24.1 million pertussis cases and over 160,000 deaths of children under five years of age in 2014 ([@bib86]). Whilst these incidence rates remain unacceptably high, the introduction of a pertussis vaccine in the 1940\'s has resulted in dramatic reductions in regions that have introduced pertussis vaccination programs ([@bib31]). For example, before the introduction of the vaccine, the incidence of pertussis in the United States of America was estimated to be approximately 180,000 annually ([@bib8]). Following vaccination, the incidence in that country fell dramatically to an estimated 1000 new cases per year in 1976. Since that time, the incidence has risen again to nearly 19,000 in 2017.

Pertussis is caused by the bacterium *Bordetella pertussis* ([@bib31]). It is an airborne disease and is spread in a similar manner to TB and diphtheria. Once a person is infected with the bacterium, it generally takes 6--20 days for the symptoms to become evident. Initially the symptoms are similar to a common cold, with a runny nose, fever and mild cough being common. These rapidly progress to the characteristic severe coughing fits, followed by a sudden inhalation, producing the 'whooping' sound that gives the disease the common name whooping cough. The disease is protracted, with the symptoms often lasting up to 10 weeks. The coughing can be so severe that it can cause subconjunctivial haemorrhages, rib fractures, hernias, urinary incontinence and vertebral artery dissection ([@bib83]).

Vaccination is the main form of pertussis control and is approximately 70--85% effective, dependent on the *B. pertussis* strain ([@bib31]). However, recent genetic shifts in the bacterium have rendered some strains less susceptible to the vaccine ([@bib53]). Furthermore, immunity conferred by vaccination is not life-long and has been estimated to only last 4--12 years ([@bib80]). If a person contracts pertussis, macrolide antibiotics including erythromycin, clarithromycin or azithromycin are generally effective. However, macrolide resistant *B. pertussis* strains have been reported ([@bib41]; [@bib42]) rendering these antibiotics of little use. Effective new therapies are urgently required.

1.4. Bacterial pneumonia {#sec1.4}
------------------------

Bacterial pneumonia is characterised by lung inflammation due to bacterial infections ([@bib5]). It is not a single disease and can be caused by multiple bacterial species including *Haemophilus influenzae, Klebsiella pnuemoniae, Moraxella catarrhalis, Pseudomonas aeruginosa, Staphyloccus aureus* and *Streptococcus pneumoniae*. Bacterial pneumonia is a significant medical burden and causes considerable loss of life annually. Indeed, lower respiratory infections (of which bacterial pneumonia is the major mortality causing disease) are one of the highest causes of death of all communicable diseases ([@bib5]; [@bib85]). The severity of bacterial pneumonia varies widely from mild to life-threatening, or even death. The severity is dependent on a number of factors including the bacterial species and strain causing the infection, the age of the infected person (children and older people tend to suffer more severe symptoms), the immunological status of the infected person, and their general health. The symptoms are generally the same irrespective of the bacterial species/strain or the age of the infected person and include chest pains, shortness of breath, frequent coughing which produces yellow or green coloured mucus, fever, lethargy and chills. In severe cases, infected individuals may develop complications including respiratory failure, sepsis, lung abscesses or empyema (accumulation of pus in the pleural cavity surrounding the lungs).

Infection with these bacteria is most frequently via similar transmission pathways as TB, diphtheria and pertussis (i.e. air-borne transmission), and is classified as community acquired pneumonia ([@bib5]). This accounts for the vast majority of bacterial pneumonia cases. However, hospital-acquired bacterial pneumonia (HCAP) is also relatively common and occurs when a sick patient (who has a compromised immune system due to an existing medical condition) contracts an infection whilst in hospital. Ventilator-acquired pneumonia (VAP) may also occur when contaminated equipment is used to ventilate a patient. However, whilst HCAP and VAP are significant issues, air-borne transmission is the major route of transmission.

In contrast to the other bacterial respiratory diseases already discussed, there are few effective vaccines to prevent bacterial pneumoniae, although vaccines are available against *Pneumonococcal* spp. ([@bib5]). Treatment for bacterial pneumonia is generally reactive and is reliant on the use of antibiotics to kill the infective bacteria. The specific antibiotic(s) used are dependent on the infective bacterium. Antibiotic therapy is generally effective against most infective strains, although resistance of bacterial pneumonia strains to antibiotics is becoming relatively common and antibiotic therapies are increasingly failing ([@bib64]). Of particular concern, extremely resistant strains of *Klebsiella pneumoniae* have been reported in China and Greece ([@bib10]). Both of these strains were resistant to nearly all frontline antibiotics. The same study reported that shortly after those resistant strains were isolated, another *K. pneumoniae* strain that was resistant to all classes of antibiotics was detected in the United States of America. This is particularly concerning as medical science has no effective treatment against that strain and new therapies are urgently required. Similarly, methicillin resistant *Staphyloccus aureus* (MRSA) and extended spectrum β-lactamase resistant (ESBL) strains of some bacterial causes of pneumonia are now relatively common ([@bib10]). The development of new therapies that are effective against these antibiotic-resistant species is urgently required.

2. An overview of bacterial respiratory diseases in South Africa {#sec2}
================================================================

The incidence of TB is particularly high in southern Africa ([@bib57]). Indeed, the WHO issues an annual global TB report on the 30 highest TB burden countries based on the number of cases and the severity of diseases burden ([@bib81]). Six southern African countries (Lesotho, Mozambique, Namibia, South Africa, Zambia, Zimbabwe) are included in that list. South Africa has the highest overall number of cases (301,000 total infections), which corresponds to the higher population numbers in South Africa compared to the other southern African countries. The TB rate as a percentage of population is approximately 5% for South Africa, which is similar to the rates in Mozambique and Namibia, and lower than the rates in Lesotho. Interestingly, the rates in Zambia (3.5%) and Zimbabwe (2%) were substantially lower and may correlate to the higher average temperatures (particularly in winter) in those countries. Alternatively, the lower rates may be due to less effective and incomplete reporting of these diseases in those countries. Due to the higher temperatures, it is likely that people in those countries spend less time in groups indoors, thus decreasing pathogen transmission. The southern African infection rates are substantially higher than the global average of 1%, demonstrating the health burden that TB has in southern Africa.

Notably, the WHO statistics only report the cases of active TB. As only approximately 10% of *M. tuberculosis* infections cause the active form of the disease, the actual infection rate may be as high as 50% of the population, providing a vast reservoir of bacteria for potent transmission of TB. Other studies have reported higher incidence of *M. tuberculosis* infection in specific populations. Screening studies in an adult population (\<30 years old) in a mining community detected *M. tuberculosis* infections in 89% of the population ([@bib30]). A similar study screened adolescent school students (12--18 years old) in rural regions of the Western Cape province of South Africa, within 100 km of Cape Town, and reported nearly 60% of the students had latent TB infections ([@bib46]). Both of these studies screened specific groups and these statistics do not necessarily represent the overall prevalence of latent *M. tuberculosis* infections in the entire southern Africa region and the prevalence in urban regions of southern Africa may be substantially different.

The Hanifa et al. study (2009) highlights the prevalence of TB on the mining industry. The conditions under which miners may work constitute ideal conditions for the transmission of *M. tuberculosis*. Miners often work in enclosed spaces underground for extended periods. If a miner has TB, airborne transmission is highly likely under those conditions. Furthermore, miners often share equipment, which may further facilitate the spread of the bacterium. High density lower socio-economic urban communities also have higher incidences of *M. tuberculosis* infections than other regions of southern Africa. High density living provides ideal conditions for airborne transmission, thereby increasing the likelihood of person to person transfer. Of concern, antibiotic resistant *M. tuberculosis* strains are highly prevalent in southern Africa, with \>90% of new infections reported to be resistant to several frontline antibiotics ([@bib81]). The high prevalence of resistant *M. tuberculosis* strains contributes to the overall burden of the disease in the region. Not only is it more difficult to treat the disease in infected people, but this also allows for further transmission of the bacterium.

The relatively low level of childhood vaccination uptake in several of the southern African countries also contributes to the levels of TB in the region. The WHO report (2019a) estimates that only 59% of children below five years of age have been immunised against TB in South Africa. This contrasts dramatically with the worldwide vaccination rates where it has been estimated that more than 90% of children below the age of five years have been vaccinated for TB. The low vaccination uptake in South Africa is surprising given the incidence of TB in the region and subsidisation of TB vaccination programs by the South African government. Vaccination is relatively cheap and is generally readily available in most areas of the country. We were unable to find a further breakdown of the vaccination statistics on a geographical and ethnic basis, but it is likely that low levels of uptake in isolated and rural communities skew the statistics for the entire country. Isolated and rural communities often have limited access to clinical care, and when medical care is available, rural populations are often poor and may be unable to afford westernised health care. Instead, rural communities are often reliant on traditional healers. However, encouraging TB vaccination programs may be effective in reducing the infection levels in southern Africa, even amongst non-vaccinated people, by providing 'herd immunity', thereby reducing transmissibility.

Not surprisingly, the incidence of *M. tuberculosis* infections is also higher in health care workers than in the general population, due to their levels of exposure to respiratory pathogens. Indeed, one study estimated that the risk of contracting TB is approximately 2.5 times higher for medical professionals than the general population in several countries with similar socio-economic profiles as southern Africa ([@bib35]). Furthermore, that study demonstrated that specific health care sectors have substantially increased risks of contracting TB. In particular, the risks to workers in emergency departments, TB treatment facilities, clinical laboratories, and internal medicine departments were particularly high rates of infection. Within those departments, paramedics, nurses, patient attendants, ward attendants and radiology technicians had substantially increased risks of contracting a *M. tuberculosis* infection. Whilst that study examined the incidence of TB in the health care sector in other countries, it is likely that similar trends occur in southern Africa.

Immuno-compromised people also have higher rates of infection than non-immunocompromised people. Indeed, the WHO report on TB in the southern African countries ([@bib81]) estimated that 59% of individuals diagnosed with TB in 2018 in South Africa also had HIV/AIDS. Of further concern, people with HIV/AIDS had a substantially worse prognosis than the general population, with approximately twice the mortality rate. Whilst the WHO report did not break the data down on the basis of age, it is likely that similar trends would occur in children and in the elderly. Both of these groups have lower immuno-competence than healthy adults. Thus, they are likely to have higher incidences of TB, and higher rates of mortality once they contract a *M. tuberculosis* infection. However, we were unable to find statistics to support this and further studies are needed for confirmation.

The other bacterial respiratory diseases generally follow similar trends to other countries with similar socio-economic profiles. As with other regions of the world, widespread diphtheria and pertussis vaccination programs in children have substantially decreased the incidence of those diseases in southern Africa. Indeed, between January 2008 and March 2015, only four cases of diphtheria were reported in South Africa. An outbreak of diphtheria occurred in South Africa in March 2015, with fifteen confirmed cases in rural Kwa-Zulu Natal, of which four died ([@bib45]). All but four of the infected people were either not vaccinated, or their vaccinations were out of date. The outbreak was rapidly contained and the incidence rates have remained low since. Similarly low rates of infection occurred throughout other southern African countries across the same period.

Pertussis is far more common than diphtheria in southern Africa. It is difficult to find incidence statistics for individual countries in southern Africa as the WHO provides figures for the African global region instead. According to the WHO, 14 million cases of pertussis were reported from a population of approximately one billion people, which equates to an infection rate of 1.4% of the population. However, vaccination programs are widespread in South Africa and have a far greater take up rate in southern Africa than in central, eastern and western Africa ([@bib83]), so it is likely that the incidence in South Africa (and other southern African countries) is substantially less than this. Pertussis is substantially more common in children than in adults and is one of the most common diseases in children under five years of age. It also has higher incidences in immuno-compromised people than in the general population. A recent study screened children hospitalised for respiratory illnesses in South Africa and reported that pertussis was the cause of approximately 7% of the cases of respiratory illness ([@bib55]). The rate was significantly higher in HIV positive children (15.8%) and in HIV exposed but negative children (10.9%) than in HIV unexposed children (5.4%). Notably, there have been marked recent increases in the incidence of pertussis in the WHO African world region. Indeed, the number of reported *B. pertussis* infections in that region has increased from approximately 1.5 million to over 14 million between 2016 and 2018 ([@bib84]). Although specific figures for South Africa are not available from the WHO, it is likely that it has similar trends for those of the rest of the Africa region. It is likely that decreased rates of pertussis vaccination uptake in recent years may contribute to this trend. Indeed, a recent report by the [@bib9] reported that pertussis vaccination rates in South Africa had decreased to 66% of the population in 2016, allowing for the resurgence of the disease in the region.

Bacterial pneumonia is common in both children and adults in southern Africa and it is the most common cause of hospitalisation in South Africa. Indeed, approximately 12 million children were hospitalised and 1.2 million children died from bacterial pneumonia in 2010 in South Africa ([@bib19]). The same study also reported that bacterial pneumonia is the second most common cause of death in South African adults. The disease is substantially more common in immune-compromised individuals (both children and adults).

Pertussis and bacterial pneumonia transmission trends are similar to TB. High density urban living allows for efficient transmission of these diseases, therefore the incidence is higher under those conditions. Unfortunately, we were unable to locate occupation specific statistics as reported for TB and further research is required in that area. However, it is likely that similar trends occur (i.e. higher rates in occupations that require workers to work together in confined spaces such as mining; high rates in health care sector professionals through greater contact with infected people). However, these trends have not been reported for pertussis and bacterial pneumonia and further studies are required to confirm this.

3. Materials and methods {#sec3}
========================

3.1. Search strategy {#sec3.1}
--------------------

Our study aimed to identify southern African plants used traditionally to treat bacterial respiratory diseases in humans. A systematic search was undertaken using a variety ethnobotanical books (Smith, 1888; [@bib79]; [@bib34]; [@bib78]; [@bib60]; [@bib76]) and ethnobotanical reviews ([@bib33], 2017; [@bib18]; Nortje and Van Wyk, 2011; [@bib65]; [@bib77]). Ethnobotanical research articles published prior to June 2020 were also searched via Google-Scholar, Science-Direct, PubMed and Scopus using the following terms as filters, and were searched both alone and as combinations: "South African", "medicinal plant", "traditional medicine", "ethnobotany", "respiratory infection" "tuberculosis", "pneumonia", "bacterial pneumonia", "pertussis", "diphtheria", "whooping cough*"*. All terms were searched alone and as combinations.

Each plant species identified by this initial search were subjected to a further literature review to establish the extent (if any) of the scientific research into the efficacy of that species. Specific criteria to filter studies included the terms ethnomedicine, southern African medicinal plants and other key words related to bacterial respiratory infections and the specific pathogens.

3.2. Eligibility criteria {#sec3.2}
-------------------------

A screening of publication titles was initially performed, and eligible publications were selected. The abstracts of were then read to ensure that the selected publications met the eligibility criteria. Full text manuscripts were retrieved for all publications that met the eligibility requirements and these were further studied.

### 3.2.1. Inclusion criteria {#sec3.2.1}

To meet the eligibility criteria for this study, a publication had to meet the following inclusion criteria:•Only English language publications published prior to June 2020 were used in the preparation of this review.•This study is non-biased and does not have taxonomic preference (although several of the studies we review targeted specific families or genera).•For the ethnobotanical studies, the plant species must be stated to be used against the specific bacterial respiratory diseases examined in this study, rather against generic symptoms.•For the screening studies, preparations prepared from plant extracts must have been screened against at least one of the pathogens responsible for the bacterial respiratory diseases. Alternatively, studies that tested the plant preparations against human or animal models with the bacterial respiratory diseases were also included in this study.•For introduced species to be included in this report, they must either be naturalised or widely cultivated, and there must be documented evidence that they are commonly used by at least one southern African ethnic group to treat viral respiratory disease.

### 3.2.2. Exclusion criteria {#sec3.2.2}

Studies with the following criteria were excluded from this study:•Studies where the species identity was in doubt. By necessity, several relatively old publications were searched (e.g. Smith, 1888; [@bib79]). Where possible, the species names were confirmed or updated using the Plant List website (<http://www.theplantlist.org/>). Where a species name could not be definitively verified, that species was omitted from this study.•Only plant species definitively described as being used to treat specific bacterial respiratory diseases are included in this study. Due to symptom similarity with numerous diseases, when a plant was described as being used to treat symptoms consistent with bacterial respiratory diseases without specifying the diseases they are used to treat were excluded from this study.•Whilst plant species that are not native to southern Africa are included in this study, introduced plant species were excluded unless there is evidence of their usage in at least one southern African traditional healing system and their widespread cultivation in southern Africa.

3.3. Data collection {#sec3.3}
--------------------

Ethnopharmacological studies from southern Africa that are linked with the treatment of bacterial respiratory disease were collected and examined in this study. Additionally, studies testing the activity of the southern African medicinal plants against the bacterial respiratory pathogens, or against infected human or animal models, were examined, irrespective of the study origin. The following data was collected:•Genus, species and family name for each species examined in the individual publications. All species names were standardised using the Plant List website (<http://www.theplantlist.org/>).•Ethnic grouping that traditionally used the plant species medicinally. Where possible, the common and ethnic names were also collected.•The plant part used and the method of preparation were collected (where available).•For screening studies, the bacterial pathogen species and (where possible) the strain were listed and the MIC values (where available) are included.•For animal and human trial studies, the animal model (where appropriate), route of administration, doses and toxicity data (where available) was noted.

All data was managed using Excel® software.

4. Results {#sec4}
==========

4.1. South African medicinal plants used traditionally to treat bacterial respiratory diseases {#sec4.1}
----------------------------------------------------------------------------------------------

One hundred and eighty-seven southern African plants which are used in at least one southern African traditional healing system to treat bacterial respiratory infections were identified following an extensive literature search ([Table 1](#tbl1){ref-type="table"} ). As indicated in our review of southern African plants to treat viral respiratory infections ([@bib16], part one), several pathogenic respiratory diseases exhibit generic symptoms that are common with other bacterial diseases, as well as viral respiratory diseases. For example, the early stage symptoms of TB are often similar to those of influenza or severe acute respiratory syndrome (SARS). Similar symptoms are also evident for numerous other non-respiratory diseases including bubonic plague, Lyme disease, malaria, measles, rabies, and the early phases of AIDS. As ethnobotanical texts may report the usage of plant species to treat the symptoms of a disease, the specific disease treated is often not definitive. For this study, we have only included plant species that have specifically been reported for the treatment of bacterial respiratory infections in humans. Where the disease pathogen targeted by a plant is ambiguous, we have excluded that species from this study. Thus, it is likely that this list underestimates the number of plant species used to treat bacterial respiratory disease.Table 1South African plants used traditionally to treat bacterial respiratory illnesses.Table 1Plant speciesFamilyCommon name(s)Plant part usedUsed forReferences*Abrus precatorius* subsp. *africanus* Verdc.FabaceaeBead vine, coral bead plant, coral bean, crabs eye, licorice vine, love bean, lucky bean creeper, prayer beads, weather vine (English), umkhokha (Zulu)Leaves, rootsUsed to treat TB and whooping cough. Preparation and application not specified.[@bib43]*Abutilon angulatum* (Guill. & Perr.) Mast.MalvaceaeUnknownRootUsed to treat bacterial pneumonia. Preparation and application are not specified.[@bib78]*Acacia eriloba* E.Mey.FabaceaeCamel thorn, giraffe thorn (English), kameeldoringboom (Afrikaans)LeavesLeaf infusions are drunk to treat bacterial pneumonia.[@bib78]*Acacia nilotica* (L.) DelileFabaceaeRedheart, scented thorn (English), lekkerreulpeul (Afrikaans)RootUsed to treat TB. Preparation and application are not specified.[@bib79]*Acacia xanthophloea* Benth.FabaceaeFever tree (English)BarkUsed to treat TB. Preparation and application are not specified.[@bib50]*Aclepias crispa* P.J.BergiusApocynaceaewitvergeet, kalmoes (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application are not specified.[@bib33], 2017*Acorus calamu*s L.AcoraceaeSweet flag (English), makkalmoes (Afrikaans), ikalamuzi (Zulu)RootVolatile compounds produced from the root are used to treat TB.[@bib79]*Adenia fruticosa* Burtt DavyPassifloraceaeGreen-stem (English)Not specifiedUsed to treat TB. Preparation and application not specified.[@bib79]*Ajuga ophrydis* Burch. ex Benth.LamiaceaeSenyarrla (Southern Sotho)RootsUsed to treat TB. Preparation and application not specified.[@bib37]*Allium cepa* L.AmaryllidaceaeOnion (English)BulbConsumed to treat whooping cough.[@bib79]*Allium sativum* L.AmaryllidaceaeGarlic (English)BulbConsumed to treat whooping cough and TB.[@bib79]*Aloe arborescens* Mill.XanthorrhoeaceaeKrantz aloe (English), kransaalwyn (Afrikaans), ikalene (Xhosa), inkalane, umhlabana (Zulu)LeavesUsed to treat TB. Preparation and application not specified.[@bib79]*Aloe ferox* Mill.XanthorrhoeaceaeCape aloe (English), Bitteraalwyn, Winkelaalwyn (Afrikaans), iKhala (Xhosa), iNhlaba (Zulu)LeavesUsed to treat TB. Preparation and application not specified.[@bib79]*Aloe maculata* All.XanthorrhoeaceaeSoap aloe, zebra aloe (English)LeavesUsed to treat TB. Preparation and application not specified.[@bib79]*Aloe noblis* Haw.XanthorrhoeaceaeGolden toothed aloeLeavesUsed to treat TB. Preparation and application not specified.[@bib79]*Aloe plicatilis* (L.) Mill.XanthorrhoeaceaeFan aloe, Franschhoek aloe (English), waaieraalwyn, Franschoekaalwyn, bergaalwyn, tongaalwyn (Afrikaans)LeavesUsed to treat TB. Preparation and application not specified.[@bib79]*Anginon difforme* (L.) B.L.Burtt.ApiaceaeWildeanys (Afrikaans)LeavesLeave infusions were drunk by the Nama to treat TB.[@bib61]*Aptosimum depressum* Burch. ex Benth.ScrophulariaceaeUnknownNot specifiedAn infusion was used as a gargle to treat diphtheria.[@bib79]*Artemisia afra* Jacq. ex Willd.AsteraceaeAfrican wormwood (English), als, alsem, wildeals (Afrikaans), lengana (Sotho, Tswana), umhlonyane (Xhosa, Zulu)LeavesThe leaves are boiled and the steam inhaled to treat whooping cough and diphtheria. The resultant infusion can also be drunk for the same purposes.[@bib78]; [@bib50];*Aspalathus cordata* (L.) R.DahlgrenFabaceaeUnknownLeavesAn infusion is drunk to treat whooping cough.[@bib79]*Aspalathus linearis* (Burm.f.) R.DahlgrenFabaceaeRed bush, bush tea (English), Rooibos (Afrikaans)LeavesAn infusion is drunk to treat TB and whooping cough.[@bib79]*Asparagus africanus* Lam.AsparagaceaeBush asparagus (English)RootRoot infusions are consumed several times per day to treat TB.[@bib79]; [@bib43]; [@bib33], 2017*Asparagus capensis* L.AsparagaceaeKatdoring (Afrikaans)RootRoot infusions are consumed several times per day to treat TB.[@bib79]; [@bib65]; [@bib33], 2017*Asparagus densiflorus* (Kunth) JessopAsparagaceaeKatdoring (Afrikaans)RootRoot infusions are consumed to treat TB.[@bib33], 2017*Asparagus falcatus* L.AsparagaceaeUnknownLeaves and rootsRoot infusions are consumed to treat TB.[@bib62]; [@bib43];*Asparagus linearis* (Brum.f.) R.DahlgrenAsparagaceaeT\'nuance, katdoring (Afrikaans)RootsRoot infusions are consumed to treat TB.[@bib77]*Asparagus retrofractus* L.AsparagaceaeMing fern (English)RootRoot infusions are consumed to treat TB.[@bib79]*Asparagus setaceus* (Kunth) JessopAsparagaceaeAsparagus fern, climbing fern, lace fern (English)RootRoot infusions are consumed several times per day to treat TB.[@bib79]*Asparagus striatus* (L.f.) Thunb.AsparagaceaeBergappel, bergappeltjie, bobbejaanappel (Afrikaans)RootRoot infusions are consumed several times per day to treat TB.[@bib79]*Asparagus suaveolens* (Burch.) BakerAsparagaceaeBushveld Asparagus, wild aspoaragus (English), katdoring (Afrikaans), mvane (Xhosa)RootRoot infusions are consumed to treat TB.[@bib79]*Astridia velutina* (L.Bolus) Dinter[Aizoaceae](http://www.theplantlist.org/1.1/browse/A/Aizoaceae/){#intref0070}UnknownSapused to treat diphtheria. Preparation and application not specified.[@bib78]*Buddleja saligna* Willd.ScrophulariaceaeFalse olive (English), witolien (Afrikaans), lelothwane (Southern Sotho), ungqeba (Xhosa), igqeba-elimhlope (Zulu)Leaves, stemsUsed to treat TB. Preparation and application not specified.[@bib50]*Callilepis laureola* DCAsteraceaeOxe-eye daisy (English), Wile margriet (Afrikaans), amafuthomhlaba, ihlamvu, impila (Zulu)RootPreparation and application methods are not specified.[@bib79]*Capparis tomentosa* Lam.CapparaceaeWooly caper-bush (English), wollerige kapperbos, wag-'n-bietjie (Afrikaans), inkunzi-ebomvu, iqwaningi, umqoqolo, ukhokhwana, umabusane (Zulu), imfishlo, intshihlo, intsihlo, umpasimani (Xhosa)Bark, RootsThe bark is burned and the smoke is inhaled to treat TB. The Venda also drank a root decoction for the same purpose.[@bib79]; [@bib62]*Carissa edulis* (Forssk.) Vahl.ApocynaceaeSimple-spined num-num, climbing num-num, small num-num (English), enkeldoringnoemnoem, ranknoemnoem, kleinnoemnoem (Afrikaans), mothokolo (North Sotho), murungulu (Venda)Root, leavesA root decoction is used by the Venda to treat TB. Leaf juice was gargled to treat diphtheria[@bib62]; [@bib77]*Carpobrotus acinaciformis* (L.) L.BolusAizoaceaeEland\'s sourfig (English), elandssuurvy (Afrikaans)LeavesThe boiled fruit is consumed to treat TB.[@bib79]*Carpobrotus edulis* (L.) N.E.Br.AizoaceaeSour fig, Cape fig, Hottentot\'s fig (English), vyerank, ghaukum, ghoenavy, hotnotsvye, Kaapvy, perdevy, rankvy (Afrikaans), ikhambi-lamabulawo, umgongozi (Zulu)LeavesA leaf decoction is consumed to treat diphtheria. Leaf juice is consumed to treat TB.al.[@bib79]; [@bib76]; [@bib65]; [@bib61]*Cassine aethiopica* Thunb.CelastraceaeSaffron wood, forest saffron (English), saffraan, bossafraan (Afrikaans)LeavesUsed to treat TB. Preparation and application not specified.[@bib50]*Cephalaria pungens* SzabóCaprifoliaceaeUnknownRootsUsed to treat TB. Preparation and application not specified.[@bib79]*Chaetachme aristata* Planch.UlmaceaeThorny elm (English), basterwitpeer (Afrikaans)LeavesUsed to treat TB. Preparation and application not specified.[@bib21]*Chamaecrista mimosoides* (L.) GreeneFabaceaeBoesmantee (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application are not specified.[@bib78]*Chenopodium ambrosioides* L.ChenopodiaceaeWormsalt (English), sinkingbossie (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application are not specified.al.; [@bib78]; [@bib50]*Chironia baccifera* L.GentianaceaeBitterbos, skilparbos (Afrikaans)Not specifiedInfusions are used to treat TB and pneumonia.[@bib33], 2017*Chrysanthemum frutescens* L.AsteraceaeParis daisy (English)RootsUsed to treat TB. Preparation and application not specified.[@bib79]*Chrysanthemum segetum* L.,AsteraceaeCorn marigold (English)LeavesDecoctions are drunk to treat TB.[@bib79]*Cinnamomum camphora* (L.) J.Presl.LauraceaeCamphor tree (English), kanferboom (Afrikaans), uroselina (Zulu)Leaves. Essential oil (distilled from the wood)The leaves are smoked by the Southern Sotho to treat TB. The bark is used to treat bacterial pneumonia, Preparation and application not specified.[@bib65]; [@bib76]; [@bib79]*Cissampelos capensis* L.f.MenispermaceaeDawidjies, fynblaarklimop (Afrikaans)LeavesInfusions are drunk to treat TB.[@bib33], 2017*Cliffortia odorata* L.f.RosaceaeWildewingerd (Afrikaans)Not specifiedAn infusion is drunk to treat diphtheria.[@bib79]*Combretum molle* R.Br. ex G.Don.CombretaceaeVelvet bush willow (English), fluweelboswilg, basterrooibos (Afrikaans), mokgwethe (Sotho), mugwiti (Venda), umBondwe-omhlope (Zulu)BarkUsed to treat TB. Preparation and application not specified.[@bib50]*Combretum platypetalum* Welw. ex M.A. LawsonCombretaceaeUnknownRootRoot decoctions are drunk to treat bacterial pneumonia[@bib78]*Croton pseudopulchellus* PaxEuphorbiaceaeSmall lavender fever-berry (English), kleinlaventelkoorsbessie, sandkoorsbessie (Afrikaans), uHubeshane (Zulu)LeavesUsed to treat TB. Preparation and application not specified.[@bib50]*Cryptocarya latifolia latifolia* Sond.LauriaceaeBastard stinkwood, broad-leaved aurel, broad-leaved quince (English), baster-stinkhout, basterswartstinkhout, breëblaarkweper, pondo-kweper (Afrikaans),umgxaleba, umgxobothi (Xhosa), umhlangwenya, umkhondweni, umdlangwenya (Zulu),BarkUsed to treat TB. Preparation and application not specified.[@bib50]*Cyclopia genistoides* (L.) Vent.FabaceaeHoneybush tea (English), heuningbos (Afrikaans)Leavesinfusions are drunk as an expectorant in people with TB.[@bib79]*Dahlia pinnata* Cav.AsteraceaeGarden dahlia (English)FlowersUsed to treat TB. Preparation and application not specified.[@bib79]*Datura metel* L.SolanaceaeThorn apple, angel\'s trumpet (English)RootDried roots are smoked to treat TB.[@bib79]*Dicoma capensis* Less.AsteraceaeKarmadik, baarbos, sandsalie (Afrikaans)LeavesDecoctions are drunk to treat TB.[@bib61]*Dichrostachys cinerea* (L.) Wight & Arn.FabaceaeKalahari Christmas tree, sickle bush, bell mimosa, Chinese lantern tree (English)Leaves and rootsLeaves and roots are burned and the smoke inhaled to treat TB and bacterial pneumonia.[@bib79]; [@bib78];*Diplorhynchus condylocarpon* (Müll.Arg.) PichonApocynaceaeWild rubber, horn-pod tree (English), horingpeulbos, melkbos (Afrikaans), muthowa (Venda)Not specifiedUsed to treat TB. Preparation and application method not specified.[@bib79]*Dodonaea viscosa* (L.) Jacq.SapindaceaeSand olive (English), sandolien, ysterbos (Afrikaans), mutata-vhana (Venda)Leaves, twigsA decoction is drunk to treat TB and diphtheria. Also useful for the treatment of bacterial pneumonia.al.[@bib79]; [@bib50]; [@bib33], 2017*Drosera capensis* L.DroseraceaeCape sundew (English), sondouw (Afrikaans)LeavesUsed to treat TB. Preparation and application not specified.[@bib50]*Ekebergia capensis* Sparm.MeliaceaeCape ash, dogplum (English), essenhout (Afrikaans), mmidibidi (Sotho)Leaves bark, rootsUsed to treat TB. Preparation and application not specified.[@bib50]*Elytropappus rhinocerotis* (L.f) Less.AsteraceaeRhinoceros bush (English)UnspecifiedUsed to treat TB. Preparation and application methods are not specified.Hulley and vanWyk, 2017*Empleurum unicapsulare* (L.f.) SkeelsRutaceaeBergboegoe (Afrikaans)UnspecifiedUsed to treat bacterial pneumonia. Preparation and application methods are not specified.Hulley and vanWyk, 2017*Erigeron canadensis* L.AsteraceaeHorseweed, coltstail, marestail, butterweed (English)LeafUsed to treat TB. Preparation and application not specified.[@bib79]*Eriocephalus africanus* L.AsteraceaeKapokbos, skaapkaroo (Afrikaans)Not specifiedInfusions are used to treat TB.Hulley and vanWyk, 2017*Erythrina humeana* Spreng.FabaceaeUmsinsana (Zulu)Not specifiedUsed to treat TB. Preparation and application not specified.[@bib17]*Eucalyptus globulus* Labill.MyrtaceaeSouthern blue gum, Tasmanian blue gum (English)LeavesThe leaves are boiled and the vapour is inhaled to treat TB and diphtheria.[@bib77]; [@bib79]*Eucela natalensis* A. DC.EbenaceaeNatal guarri, Natal ebony, large-leaved guarri (English), Natalghwarrie, berggwarrie, swartbasboom (Afrikaans), umTshekisani, umKhasa (Xhosa), iDungamuzi, iChitamuzi, umZimane, umTshikisane, inKunzane, inKunzi-emnyama, umHlalanyamazane, umAnyathi (Zulu)RootsUsed to treat TB. Preparation and application not specified.[@bib50]*Euphorbia heterophylla* L.EuphorbiaceaeJapanese poinsettia, desert poinsettia, painted spurge, milkweed (English)Leaves and flowersUsed to treat TB. Preparation and application not specified.[@bib79]*Euphorbia neriifolia* L.EuphorbiaceaeMilk hedge, milk bush, oleander spurge, oleander-leaved euphorbia (English), melkbos (Afrikaans)Stem latexUsed to treat whooping cough. Preparation and application method not specified.[@bib79]*Felicia filifolia* (Vent.) Burtt DavyAsteraceaeSteenbokbossie, vaderlandsrapuisbos (Afrikaans)Not specifiedUsed for the treatment of TB. Preparation and application not specified.[@bib33], 2017*Ficus carica* L.MoraceaeCommon fig (English)Leaves and rootsA decoction of the roots and leaves is drunk to treat diphtheria.[@bib79]; [@bib33], 2017*Ficus sur* ForsskMoraceaeCape fig, broom cluster fig (English)Root and barkThe Zulu drink a decoction of the root and bark to treat TB.al.[@bib79]; [@bib62]; [@bib43]*Ficus sycomorus* L.MoraceaeSycamore fig, common cluster fig, mulberry fig (English), trosvy, geelrriviervy, geelstamvy, gewone trosvy, wildevyeboom, sycomorusvy (Afrikaans), mogo, mogoboya, mohlole (Sotho), muhuvhoya, muhuyu, muhuyu-lukuse, mutole, muvhuyu-vhutwa (Venda), mogoboya, umkhiwane isikhukhuboya, umncongo, umkhiwane (Zulu)FruitA fruit infusion is drunk by the Venda to treat TB.[@bib62]*Galenia africana* L.AizoaceaeYellow bush (English), brakkraalbossie, geelbos, kraalbos, muisbos, muisgeelbossie, perdebos (Afrikaans), iqina (Xhosa)LeavesUsed to treat TB. Preparation and application not specified.[@bib50]*Garcinia polyantha* Oliv.ClusiaceaeUnknownBarkUsed to treat TB. Preparation and application not specified.[@bib50]*Ginkgo biloba* L.GinkgoaceaeGinkgoLeavesDecoctions and infusions are drunk to treat TB.[@bib79]*Glycyrrhiza glabra glabra* L.FabaceaeLiquorice, licorice (English)RhizomeRoot infusions are used to treat TB.[@bib79]; [@bib76]*Gomphocarpus fruticosus* (L.) W.T.AitonApocynaceaeMilkweed (English), melkbos, tontelbos (Afrikaans), lebegana, lereke-la-ntja (Sotho), modimolo (Southern Sotho), umsinga-lwesalukazi (Zulu)LeavesUsed to treat TB. Preparation and application method not specified.[@bib79]; [@bib76];*Gunnera perpensa* L.GunneraceaeWild rhubarb, river pumpkin (English), wilde ramenas, ravierpampoen (Afrikaans), qobo (Sotho), rambola-vhadzimu (Venda), iphuzi, ighobo (Xhosa), ugobhe (Zulu)RootsUsed to treat TB. Preparation and application method not specified.[@bib50]*Gymnosporia buxifolia* (L.) Szyszył.Celestraceaelemoendoring, wondedoring, pendoringbos (Afrikaans)Not specifiedUsed to treat TB. Preparation and application not specified.[@bib33], 2017*Helianthus tuberosus* L.AsteraceaeJerusalem artichoke (English)Root/tuberUsed to treat TB. Preparation and application not specified.[@bib79]*Helichrysum crispum* (L.) D.Don.AsteraceaeHottentot\'s Bedding (English), Hotnotskooigoed, Hottentotskooigoed, Hottentotskruie, Kooigoed (Afrikaans)Leaves, whole plantUsed to treat TB. Preparation and application not specified.[@bib50]*Helichrysum imbricatum* (L.) Less.AsteraceaeGold-and-silver (English)Not specifiedUsed as a remedy for whooping cough. Preparation and application not specified.[@bib79]; [@bib50];*Helichrysum krausii* Sch. Bip.AsteraceaeStraw everlasting (English), sewejaartjie (Afrikaans), isipheshane, isiqoqo (Zulu)Flowers and seedsDried flowers and seeds are smoked to treat TB.[@bib79]; [@bib50];*Helichrysum melanacme* DC.AsteraceaeHotnotskooigoed (Afrikaans)Leaves, whole plantUsed to treat TB. Preparation and application not specified.[@bib50]*Helichrysum nudifolium* (L.) Less.AsteraceaeEverlastings (English), hottentotsteebossie, kooigoed (Afrikaans), isicwe, indlebe zebhokwe, undleni (Xhosa), icholocholo, imphepho (Zulu)Leaves, whole plantUsed to treat TB. Preparation and application not specified.[@bib50]*Helichrysum odoratissimum* (L.) SweetAsteraceaeEverlantings (English), kooigoed (Afrikaans) imphepho (Zulu)Leaves, whole plantUsed to treat TB. Preparation and application not specified.[@bib50]*Helichrysum vestitum* (L.) Willd.AsteraceaeCape snow (English)Not specifiedUsed to treat diphtheria. Preparation. Application not specified.; [@bib79]; [@bib50]*Helipterum eximium* (L.) DC.AsteraceaeUnknownNot specifiedUsed to treat diphtheria. Preparation and application not specified.[@bib79]*Helipterum speciosissimum* (L.) DC.AsteraceaeUnknownNot specifiedUsed to treat diphtheria. Preparation and application not specified.[@bib79]*Helipterum variegatum* DC.AsteraceaeUnknownNot specifiedUsed to treat diphtheria. Preparation and application not specified.[@bib79]*Hermannia salviifolia* L.f.MalvaceaeKatjiedrieblaar (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application not specified.[@bib33], 2017*Hoodia gordonii* (Masson) Sweet ex Decne.ApocynaceaeHoodia, ghaap, kakimas (Afrikaans)Fleshy stemsUsed to treat TB. Preparation and application not specified.[@bib79]*Hoodia pilifera subsp.* annulata (N.E. Br.) BruynsApocynaceaeUnknownFleshy stemsUsed to treat TB. Preparation and application method not specified.[@bib79]*Hypericum perforatum* L.HypericaceaeSt John\'s wort (English)Roots, leaves and flowersDecoctions and infusions are drunk to treat TB.[@bib79]*Indigofera tinctoria* L.FabaceaeTrue indigo (English)Juiceconsumed to treat whooping cough.[@bib79]; [@bib43];*Jatropha zeyheri* Sond.EuphorbiaceaeVerfbol (Afrikaans), sefapabadia (Sotho), ugodide (Zulu)UnspecifiedUsed to treat TB. Preparation and application not specified.[@bib79]*Lactuca sativa* L.AsteraceaeLettuce (English)Whole plantUsed to treat TB. Preparation and application not specified.[@bib79]*Lannea edulis* (Sond.) Engl.AnacardiaceaeWild grape (English), wildedruif (Afrikaans), muporotso (Venda)RootDecoctions and infusions of the root bark is drunk to treat whooping cough.[@bib76]*Leonotis leonoris* (L.) R.Br.LamiaceaeWild dagga (English), wildedagga, duiwelstabak (Afrikaans), mvovo (Xhosa), uyshwala-bezinyoni (Zulu)Leaves and stemsA tincture is drunk to treat TB and whooping cough.[@bib79]; [@bib62];*Leucaena leucocephala* (Lam.) de WitFabaceaeWild tamarind, wild lead tree (English)Bark leaves, seedsUsed to treat TB. Preparation and application not specified.[@bib21]*Lessertia frutescens* (L.) Goldblatt & J.C. ManningFabaceaeKeurtjie, beeskeurtiebos, kankerbos (Afrikaans)Not specifiedAn infusion is used to treat TB.[@bib33], 2017*Leyssera gnaphalioides* L.AsteraceaeSkilpadteebossie, hongertee, duinetee, teringteebos Afrikaans)LeafAn infusion is drunk to treat TB.[@bib79]; [@bib50]*Malva neglecta* Wallr.MalvaceaeLow mallow (English)RootsDecoctions and infusions are drunk to treat TB.[@bib79]*Malva paviflora* L.MalvaceaeMarshmallow, cheeseweed mallow, little mallow, small flower mallow (English)RootsDecoctions and infusions are drunk to treat TB.[@bib78]*Matricaria chamomilla* L.AsteraceaeGerman chamomile, wild chamomile, scented mayweed (English)Not specifiedUsed to treat diphtheria and TB. Preparation and application not specified.[@bib79]*Maytenus heterophylla* (Eckl. & Zeyh.) N.RobsonCelestraceaeGewone pendoring (Afrikaans)LeavesUsed to treat TB. Preparation and application not specified.[@bib50]*Melilotus alba* Ledeb.FabaceaeWhite sweet clover (English)Whole plantDecoctions and infusions are drunk to treat TB.[@bib79]*Melolobium candicans* (E.Mey.) Eckl. & Zeyh.FabaceaeWild dagga (English), wildedagga (Afrikaans)Leaves and stemsA decoction of the leaves and stems is drunk to treat TB.[@bib18]*Mentha longifolia* (L.) L.LamiaceaeWild mint (English), kruisement, balderjan (Afrikaans), koena-ya-thabo (Sotho), inixina, inzinziniba (Xhosa), ufuthana, lomhlanga (Zulu)Leaves, roots and stemsUsed to treat TB, whooping cough and diphtheria. Preparation and application method not specified.[@bib79]*Mesembryanthemum tortuosum L.*AizoaceaeKoegoed, kanna (Afrikaans)Not specifiedUsed to treat TB. Preparation and application not specified.[@bib33]2017*Montinia caryophyllacea* Thunb.MontiniaceaePepper-bush, wild clove bush (English), bergklapper, peperbos (Afrikaans)LeavesThe dried pulverised leaves are used as a snuff to treat TB.[@bib78]*Mundulea sericea* (Willd.) A.Chev.FabaceaeCork bush, silver bush, (English), kurkbos, olifantshout, visboontjie, visgif, mangaanbos (Afrikaans), mosetla-thlou (Sotho), mukunda-ndou (Venda), umsindandlovu (Zulu)Bark and rootsUsed to treat TB. Preparation and application not specified.[@bib79]*Nasturtium officinale* R.Br.BrassicaceaeWatercress (English)Whole plantUsed to treat TB. Preparation and application not specified.[@bib79]*Nicotiana glauca* GrahamSolanaceaeMustard tree, tree tobacco (English), tabakboom, wildetabak, volstruisgifboom (Afrikaans), mohlafotha (Sotho)LeavesPowdered leaves are used as a snuff to treat TB.[@bib78]*Nidorella anomala* SteetzAsteraceaeUnknownWhole plantUsed to treat TB. Preparation and application not specified.[@bib50]*Nidorella auriculata* DC.AsteraceaeUnknownWhole plantUsed to treat TB. Preparation and application not specified.[@bib50]*Olea europea* L.OlacaceaeWild olive (English) olienhout (Afrikaans), mohlware (Sotho), umnquma (Zulu, Xhosa), mutlhwari (Venda)LeavesA leaf decoction is used as a gargle to treat diphtheria.[@bib79]; [@bib78];*Oncosiphon suffruticosum* (L.) KällersjöAsteraceaeStinkkruid, wirmkruid (Afrikaans)Whole plantAn infusion is drunk to treat bacterial pneumonia.[@bib76]*Opuntia ficus-indica* (L.) Mill.CactaceaeIndian pear (English), turksvy (Afrikaans)LeavesLeaf infusions are drunk to treat whooping cough.[@bib78]*Opuntia vulgaris* Mill.CactaceaePrickly pear (English)LeavesA leaf infusion is consumed to treat whooping cough.[@bib79]*Pegolettia baccharidifolia* Less.AsteraceaeGhwarrieson, heuningdou (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application not specified.[@bib33]2017*Pelargonium graveolens* L\'Hér.GeraniaceaeRose geranium (English), wildemalva (Afrikaans)LeavesLeaves are steamed and vapours are inhaled to treat TB.[@bib76]*Pelargonium myrrhifolium* (L.) L\'HérGeraniaceaeUnknownTuberUsed to treat TB. Preparation and application not specified.[@bib77]*Pelargonium ramosissimum* Willd.GeraniaceaeDassieboegoe (Afrikaans)TuberUsed to treat TB. Preparation and application not specified.[@bib77]*Pelargonium rentiforme* CurtisGeraniaceaeKidney-leaved pelargonium (English), rooirabas (Afrikaans), iyeza lesikhali, ikubalo, umsongelo (Xhosa)TuberUsed to treat TB. Preparation and application not specified.[@bib50]*Pelargonium sidoides* DC.GeraniaceaeBlack pelargonium (English), kalwerbossie, rabassam (Afrikaans), ikubalo, iyeza lesikhali (Xhosa), khoara-e-nyenyane (Southern Sotho)TuberUsed to treat TB and pneumonia. Preparation and application not specified.[@bib50]; [@bib33]2017*Pelargonium triste* (L.) L\'HérGeraniaceaeKaneelbol, rooirabas (Afrikaans)TuberUsed to treat TB and pneumonia. Preparation and application not specified.[@bib65]*Pentanisia prunelloides* (Klotzsch) Walp.RubiaceaeWild verbena (English), sooibrandbossie (Afrikaans), setimamollo (Sotho), icimamlilo (Zulu)RootsThe Xhosa drink a root infusion to treat TB.[@bib79]; [@bib76]; [@bib65]; [@bib43]*Pentzia incana* (Thunb.) KuntzeAsteraceaeSkaapkaroobos, ankerkaroo, kleinskaapkaroobos (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application not specified.[@bib33]2017*Pharnaceum lineare* L. f.MolluginaceaeDroëdaskruie (Afrikaans)Not specifiedAn infusion is consumed to treat TB.[@bib79]; [@bib77];*Polycarpaea corymbosa* (L.) Lam.CaryophyllaceaeOld man\'s cap (English)Not specifiedUsed to treat TB. Treatment and application not specified.[@bib79]*Polygala fruticosa* P.J. BergiusPolygonaceaeButterfly bush, heart-leaf polygala (English), ertjieblom (Afrikaans), ulopesi, ulapesi, umabalabala (Xhosa), ithethe (Zulu)RootsRoot decoctions are used by the Zulu to treat TB.[@bib79]; [@bib43];*Polygala myrtifolia* L.PolygonaceaeSeptember bush (English), septemberbossie, augustusbossie, blouertjie, langelede (Afrikaans), ulopesi, ulapesi, umabalabala (Xhosa), uchwasha (Zulu)Aerial partsUsed to treat TB. Treatment and application not specified.[@bib50]*Polygonum aviculare* L.PolygonaceaeKnotgrass, bird weed, pig weed (English)Not specifiedUsed to treat TB. Treatment and application not specified.[@bib79]*Polysiphonia virgata* (C. Agardh.) SprengelRhodomeleaceaeRed algae (English)Not specifiedUsed to treat TB. Treatment and application not specified.[@bib50]*Protea nitida* Mill.ProtaceaeWaboom (Afrikaans)Not specifiedUsed to treat TB and pneumonia. Treatment and application not specified.[@bib33]2017*Prunus africana* (Hook.f.) KalkmanRosaceaeRed stinkwood, African almond (English), rooistinkhout, Afrika-amandel, Wilde-kersieboom (Afrikaans), inyazangoma-elimnyama, inkokhokho, ngubozinyeweni, umdumezulu (Zulu); uMkakase, inyazangoma, itywina-elikhul, Umkhakhase (Xhosa), mogohloro (Sotho), mulala-maanga (Venda)BarkUsed to treat TB. Treatment and application not specified.[@bib50]*Prunus cerasus* L.RosaceaeSour cherry, tart cherry, dwarf cherry (English)LeafUsed to treat TB. Treatment and application not specified.[@bib79]*Prunus persica* (L.) BatschRosaceaePeach tree (English)LeavesUsed to treat whopping cough. Preparation and application not specified.[@bib79]*Pteronia camphorata* (L.) L.AsteraceaeWakkerbos, koorsbos (Afrikaans)Leaves and twigsLeaf and twig infusions are drunk to treat TB.[@bib61]*Quercus* spp.FagaceaeOak (English)BarkThe bark is boiled and the fumes inhaled to treat diphtheria[@bib79]*Rapanea melanophloeos* (L.) MezPrimulaceaeCape beech (English); boekenhout, beukehout (Afrikaans), isiCalabi, umaPhipha, iKhubalwane, isiQalaba sehlati (Zulu), isiQwane sehlati (Xhosa)Leaves and twigsUsed to treat TB. Preparation and application not specified.[@bib50]*Rhynchosia caribaea* (Jacq.) DC.FabaceaeUnknownRootsA root extract is consumed to treat bacterial pneumonia.[@bib78]*Rhamnus prinoides* L\'HérRhamnaceaeMofifi (Southern Sotho)BranchesUsed to treat bacterial pneumonia. Preparation and application not specified.[@bib37]*Ricinus communis* L.EuphorbiaceaeCastor bean, castor oil plant (English)LeavesUsed to treat TB. Preparation and application not specified.[@bib79]*Rumex crispus* L.PolygonaceaeYellow dock (English)Whole plantUsed to treat TB. Preparation and application methods are not specified.[@bib50]*Salvia africana-lutea* L.LamiaceaeBloebloomsalie (Afrikaans)Not specifiedA tincture is drunk to treat whooping cough.[@bib79]*Salvia chamdaeagnea* Berg.LamiaceaeBloublomsalie (Afrikaans)Leaves and flowersUsed to treat whooping cough. Preparation and application method not specified.[@bib79]*Salvia microphylla* KunthLamiaceaeRooisalie, rooiblomsalie (Afrikaans)Not specifiedInfusions are drunk to treat bacterial pneumonia.[@bib33]2017*Schinus molle* L.AnacardiaceaePeruvian pepper (English), peperboom (Afrikaans)Not specifiedUsed to treat bacterial pneumonia. Preparation and application not specified.[@bib33]2017*Searsia lancea* (L.f.) F.A. BarkleyAnacardiaceaeMakkaree, kareeboom (Afrikaans)Not specifiedInfusions are drunk to treat bacterial pneumonia.[@bib33]2017*Securidaca longpedunculata* Fresen.PolygalaceaeViolet tree (English), krinkhout, rooipeultjie, seepbasboom (Afrikaans), mpesu (Venda), iphuphuma (Zulu)RootsA decoction is consumed by the Venda to treat TB.[@bib62]*Senecio serratuloides* DC*.*AsteraceaeTwo-day cure (English), ichazampukane, insukumbili, umaphozisa umkhuthelo (Zulu)Aerial partsUsed to treat TB. Preparation and application not specified.[@bib50]*Solanum nigrum* L.SolanaceaeBlack nightshade (English)LeavesFresh leaves are consumed to treat TB.[@bib79]*Solanum retrofractum* VahlSolanaceaeNastergal, nasgal (Afrikaans)Not specifiedUsed to treat TB. Preparation and application not specified.[@bib33]2017*Spergula arvensis* L.CaryophyllaceaeCorn spurry (English)Whole plantAn essential oil used to treat TB.[@bib79]*Strophanthus grandiflorus* (N.E.Br.) GilgApocynaceaeUnknownWhole plantAn alcohol extract is consumed to treat TB.[@bib79]*Sutherlandia frutescens* (L.) R.Br.FabaceaeCancer bush (English), kankerbos (Afrikaans), 'musa-pelo, motlepelo (Sotho), insiswa, unwele (Xhosa, Zulu)LeavesA decoction is used to treat TB.[@bib61]*Syzygium cordatum* Hochst. ex KraussMyrtaceaeWaterberry (English), waterbessie, waterboom (Afrikaans), undoni (Zulu), umswi, umjomi (Xhosa), mawthoo (Southern Sotho), motlho (Northern Sotho), mutu (Venda)LeavesUsed by the Zulu to treat TB. Preparation and application not specified.[@bib79]; [@bib34]; [@bib17];*Syzygium gerrardii* (Harv. ex Hook.f.) Burtt DavyMyrtaceaeUnknownLeavesUsed by the Zulu to treat TB. Preparation and application not specified.[@bib79]; [@bib50]*Tabernaemontana elegans* StapfApocynaceaeToad tree (English), laeveldse paddaboom (Afrikaans), umKhahlwana, umKhadu (Zulu)Leaves, rootsUsed to treat TB. Preparation and application not specified.[@bib62]; [@bib21]*Taraxacum officinale* (L.) Weber ex F.H.WiggAsteraceaeDandelion (English)Flowers, leaves, roots, whole plantUsed to treat TB. Extracts were consumed orally to treat tuberculosis.[@bib69]; [@bib70]; [@bib79]*Terminalia phanerophlebia* Engl. & DielsCombretaceaeLebombo cluster-leaf (English), lebombotrosblaar (Afrikaans), amaNgwe-amnyama, amaNgwe-omphofu (Zulu)RootsUsed to treat TB. Preparation and application not specified.[@bib43]*Terminalia sericea* Burch. ex DC.CombretaceaeSilver cluster leaf (English), vaalboom (Afrikaans), mususu (Venda)Roots and leavesDecoctions and infusions are consumed to treat bacterial pneumonia.[@bib50]; [@bib76]; [@bib87];*Tetradenia riparia* (Hochst.) CoddLamiaceaeMisty plume bush, ginger bush (English), gemerbos, watersalie (Afrikaans), iboza, ibozane (Zulu)Leaves, rootsUsed to treat TB. Preparation and application not specified.[@bib50]*Thesium hystrix* A.W. HillSantalaceaeKleinswartstorm (Afrikaans)RootLarge volumes of a root decoction are drunk to treat TB.[@bib70][@bib79]; [@bib76]*Thymus serpyllum* L.LamiaceaeBreckland thyme, wild thyme, creeping thyme, elfin thyme (English)Leaves and flowersUsed to treat whooping cough. Preparation and application methods are not specified.[@bib70]; [@bib79];*Thymus vulgaris* L.LamiaceaeGerman thyme, common thyme (English)LeavesLeaf essential oil is used to treat whooping cough. Application methods is not specified.[@bib70]; [@bib79]; [@bib50];*Trachyandra laxa* (N.E.Br.) Oberm.XanthorrhoeaceaeUnknownRootsUsed to treat whooping cough. Preparation and application are not specified.[@bib78]*Trema orientalis* (L.) BlumeCannabaceaePigeon wood (English), hophout (Afrikaans)Leaves and fruitInfusions of the leaves and fruit are drunk to treat bacterial pneumonia.[@bib78]*Trichilia emetica* VahlMeliaceaeIxolo, umathunzini, umkhula (Zulu)LeavesDecoctions are used to treat pneumonia and whooping cough.[@bib87]*Trifolium pratense* L.FabaceaeRed clover (English)FlowersInfusions are drunk to treat TB and whooping cough.[@bib70]; [@bib79];*Tulbaghia alliacea* L.f.AmaryllidaceaeWild garlic, woodland garlic (English), wildeknoflok (Afrikaans), molela (Southern Sotho), ishaladilezinyoka, umwelela (Zulu)BulbsUsed to treat TB. Preparation and application not specified.[@bib70]; [@bib79]; [@bib77]*Tulbaghia maritima* VosaAmaryllidaceaeUnknownBulbsUsed to treat TB. Preparation and application not specified.[@bib70]; [@bib79]*Tulbaghia violacea* Harv.AmaryllidaceaeWild garlic (English), wilde knoffel (Afrikaans), isihaqa (Zulu)BulbsDecoctions are drunk to treat TB.[@bib65]; [@bib70]; [@bib79]; [@bib76]*Urtica urens* L.UrticaceaeAnnual nettle, burning nettle, sting nettle bush, dwarf stinging nettle (English), brandnekel (Afrikaans)BarkBark infusions are drunk to treat TB, pneumonia and whooping cough.[@bib79]; [@bib77]; [@bib33]2017*Viscum capense* L. f.SantalaceaeCape mistletoe (English), lidjiestee, voelent (Afrikaans)Whole plantUsed to treat TB. Preparation and application not specified.[@bib65]*Vitis vinifera* L.VitaceaeCommon grape (English)FruitA syrup prepared by boiling the fruit juice is used in the Transvaal to treat diphtheria.[@bib79]*Warburgia salutaris* (G.Bertol.) Chiov.CanellaceaePepper-bark tree (English), peperbasboom (Afrikaans), mulanga, manaka (Venda), isibhaha (Zulu)BarkUsed to treat TB. Preparation and application not specified.[@bib50]*Withania somnifera* (L.) DunalSolanaceaeIndian ginseng, poison gooseberry, winter cherry (English), bitterappelliefie, koorshout (Afrikaans), ubuvuma (Xhosa), ubuvimbha (Zulu)RootAlcohol root extracts are drunk to treat TB.[@bib79]*Zanthoxylum capensis* (Thunb.) Harv.RutaceaeKnobwood (English)BarkThe Zulu use a root bark decoction to treat TB.[@bib79]*Ziziphus mucronata* Willd.RhamnaceaeBuffalo thorn (English), blinkblaar-wag-\'n-bietjie (Afrikaans), umphafa, umlahlankosi, isilahla (Zulu), umphafa (Xhosa), mutshetshete (Venda), mokgalô, moonaona (Sotho)Leaves, bark and rootsA decoction of the leaves, roots and bark is drunk to treat TB.[@bib50]; [@bib72]

The relatively high number of plant species used to treat bacterial respiratory diseases may relate to the seriousness and relative prevalence of these infections. Indeed, the vast majority of the plants recorded for use against bacterial respiratory infections were used against bacterial pneumonia (139 species) or TB (81 species). Both of these diseases are relatively common in southern Africa and produce relatively high mortality rates. It is therefore perhaps not surprising that high numbers of plant species were identified for the treatment of these diseases.

Many of the ethnobotanical books, reviews and primary studies used in this review did not specify the preparation of the traditional medicine or how it was used and further studies are required to clarify this. However, many of the recent ethnobotanical surveys did report these details, further emphasising the importance of updated ethnobotanical information. From those studies, a further trend was also evident: decoctions and infusions were most widely used in the treatment of bacterial respiratory infections, with 64 plant-based medicines reported to be used in these ways. Previous studies have also reported that decoctions and infusions are the most common methods for treating most pathogenic diseases ([@bib2]; [@bib4]; [@bib13]; [@bib12]; [@bib18]; [@bib33], 2017; Nortje and Van Wyk, 2011; [@bib65]). Tinctures were prepared and consumed for a further four species, volatiles targeted from three species via inhalation, and a syrup was prepared and consumed from the fruit of various species. This contrasts dramatically with the preparation and usage of plant species to treat viral respiratory diseases, where inhalation was the main method of administration (unpublished results). The use of southern African plants to treat viral respiratory plants will be the basis of another manuscript in preparation.

A wide variety of families of southern African plant species including Apiaceae, Asparagaceae, Asphodelaceae, Apocynaceae, Asteraceae, Brassicaceae, Celastraceae, Combretaceae, Euphorbiaceae, Fabaceae, Lamiaceae, Lauraceae, Malvaceae, Moraceae, Myrtaceae, Polygonaceae, Rosaceae and Solanaceae ([Fig. 1](#fig1){ref-type="fig"} ) were traditionally used to treat bacterial respiratory diseases. Although the bioactivity of several of these species has already been screened against bacterial respiratory pathogens via *in vitro* testing ([Table 2](#tbl2){ref-type="table"} ), most species are yet to be screened against respiratory bacterial pathogens. Asteraceae (33 species) and Fabaceae (20 species) were commonly used traditionally to treat bacterial respiratory diseases ([Fig. 1](#fig1){ref-type="fig"}). Lamiaceae (9 species), Asparagaceae (9 species), Apocynaceae (8 species), Xanthorrhoeaceae (6 species), Aisoaceae, Geraniaceae, Euphorbiaceae, Polygonaceae and Solanaceae were also well represented with 5 species each. Four members of Combretaceae, and Malvaceae were also identified, as well as three members each of Amaryllidaceae, Celastraceae, Moraceae, Myrtaceae and Rosaceae. Two or less species of fourty-one other families were also identified as being traditionally used to treat bacterial respiratory diseases.Fig. 1The number of southern African plant species per family related to southern African medicinal plants for the treatment of bacterial respiratory infections. Others refers to the number of other genuses (not named individually) that are represented by the indicated number of species.Fig. 1Table 2Scientific evaluations of the inhibitory activity of South African plants against bacterial respiratory pathogens.Table 2Plant speciesFamilyCommon name(s)Extract testedTest micro-organismActivityReferences***Acacia nilotica* (L.) Delile**FabaceaeScented-pod acacia (English), lekkerruikpeul (Afrikaans), mogohlo (Sotho), umNqawe (Zulu)Leaf, bark and root extracts*K. pneumoniae*MIC = 780 μg/mL[@bib23]*Acacia sieberiana* DC.FabaceaePaperbark thorn (English), papierbasdoring (Afrikaans), mphoka (Northern Sotho), musaunga (Venda), umKhamba (Zulu)Leaf extracts*K. pneumoniae*MIC = 800--2000 μg/mL[@bib72]; [@bib23]***Acacia xanthophloea* Benth.**FabaceaeFever tree (English)Bark extracts*M. tuberculosis*500 μg/mL[@bib38]Leaf, bark and root extracts*K. pneumoniae*800 μg/mL[@bib23]*Acanthospermum glabratum* (DC.) WildAsteraceaeUnknownWhole plant extracts*M. smegmatis* (model for TB)MIC = 670 μg/mL[@bib87]*K. pneumoniae*MIC = 3300 μg/mL*Agathosma betulina* (P.J.Bergius) PillansRutaceaeBuchu (English), boegoe, rondeblaarboegoe (Afrikaans)Leaf extracts*K. pneumoniae*MIC = 1876 μg/mL[@bib14]*Aloe barberae* DyerXanthorrhoeaceaeTree aloe (English)Leaf extracts*K. pneumoniae*MIC = 780 μg/mL[@bib58]*Aloe marlothii* A.BergerXanthorrhoeaceaeMountain aloe, flat-flowered aloe (English), bergalwyn (Afrikaans), inhlaba, umhlaba (Zulu)Leaf extracts*M. smegmatis* (model for tuberculosis)MIC = 3330 μg/mL[@bib87]*K. pneumoniae*MIC = 2670 μg/mL*Abrus precatorius* subsp. *africanus* Verdc.FabaceaeBead vine, coral bead plant, coral bean, crabs eye, licorice vine, red bead vine (English), umkhokha (Zulu)Leaf and seed extracts*M. arum* (model for TB)MIC = 780 μg/mL (leaf)[@bib43]*K. pneumoniae*MIC = 1560 μg/mL (seed)*Androstachys johnsonii* PrainPicrodendraceaeIronwood (English), musimbiri (Venda)Root bark and leaf extracts*K. pneumoniae*MIC = 3000 μg/mL[@bib66]*P. aeruginosa*MIC = 620 μg/mL*Artemisia afra* Jacq. ex Willd.AsteraceaeAfrican wormwood (English), als, alsem, wildeals (Afrikaans), lengana (Sotho, Tswana), umhlonyane (Xhosa, Zulu)Leaf extracts*M. tuberculosis*Inactive[@bib49]*M. smegmatis* (model for TB)MIC = 1563 μg/mL*M. arum* (model for TB)MIC = 1560 μg/mL[@bib7]*K. pneumoniae*MIC = 1560 μg/mL***Asparagus africanus* Lam.**AsparagaceaeBush asparagus (English)Leaf extracts*M. arum* (model for TB)MIC = 390 μg/mL[@bib43]*K. pneumoniae*MIC = 1560 μg/mL***Asparagus falcatus* L.**AsparagaceaeUnknownLeaf extracts*H. influenzae*MIC\>1000 μg/mL[@bib62]*M. arum* (model for TB)MIC = 390 μg/mL[@bib43]*K. pneumoniae*MIC = 3130 μg/mL*Ballota africana* (L.) Benth.Lamiaceaekattekruid, kattekruie (Afrikaans)Leaf extracts*K. pneumoniae*MIC = 379 μg/mL[@bib14]*Bauhinia petersiana* BolleFabaceaeLarge white bauhinia (English), mubondo, mumwando, mun\'ando or mupondo (Shona)Leaf and root extracts*M. tuberculosis*MIC = 312 μg/mL[@bib21]*Berchemia discolor* (Klotzsch) Hemsl.RhamnaceaeBird plum, brown ivory (English), voëlpruim (Afrikaans), mogokgomo (Sepedi), nmumu, ubalatsheni-omkhulu, umadlozane, umhlungulo, uvuku (Zulu)Bark acetone extract*M. tuberculosis*MIC = 10.5--12.5 μg/mL[@bib29]*Brachylaena discolor* DCAsteraceaeCoast silver oak (English), kusvaalbos (Afrikaans), phahla (Zulu), mphahla (Sotho), umPhahla (Xhosa)Leaf extracts*M. smegmatis* (model for TB)MIC = 900 μg/mL[@bib87]*K. pneumoniae*MIC = 4000 μg/mL*Bridelia cathartica* Bertol.PhyllanthaceaeBlue sweetberry, knobby bridelia (English)Leaf extracts*M. smegmatis* (model for TB)MIC = 670 μg/mL[@bib87]*K. pneumoniae*MIC = 4000 μg/mL*Bridelia micrantha* (Hochst.) Baill.PhyllanthaceaeMunzere (Venda)Root, bark and seed extracts*K. pneumoniae*MIC = 6000 μg/mL[@bib66]*P. aeruginosa*MIC = 6000 μg/mLBark acetone extract*M. tuberculosis*MIC = 25 μg/mL[@bib29]*Brunsvigia grandiflora* Lindl.AmaryllidaceaeGiant candellabria (English), reusekandelaarblom (Afrikaans)Bulb extracts*M. arum* (model for TB)MIC = 3130 μg/mL[@bib43]*K. pneumoniae*MIC = 3130 μg/mL*Calpurnia aurea* (Aiton) Benth.FabaceaeCalpurnia, wild laburnum, Natal laburnum, Cape laburnum (English), geelkeurboom, geelkeur, Natalse geelkeur (Afrikaans), inDloli, umSitshana (Xhosa), umKhiphampethu, inSiphane-enkulu, umHlahlambedu, umLalandlovana (Zulu)Leaf extracts*K. pneumoniae*MIC = 80 μg/mL[@bib22]***Carpobrotus edulis* (L.) N.E.Br.**AizoaceaeSour fig, Cape fig, Hottentot\'s fig (English), vyerank, ghaukum, ghoenavy, hotnotsvye, Kaapvy, perdevy, rankvy (Afrikaans), ikhambi-lamabulawo, umgongozi (Zulu)Leaf extracts*M. arum* (model for TB)MIC = 3125 μg/mL[@bib7]*K. pneumoniae*MIC = 320--1040 μg/mL*Cassia fistula* L.FabaceaePurging cassia, holden shower tree (English)Flower extract*K. pneumoniae*Inactive[@bib20]; [@bib7][@bib14]*P. aeruginosa*Up to 13 mm zones of inhibition in disc diffusion assay. MIC not determined.*Cassia petersiana* (Bolle) LockFabaceaeDwarf Cassia (English), apiespeul (Afrikaans), Munembenembe (venda), Uhwabile, Umnembenembe (Zulu)Bark acetone extract*M. tuberculosis*MIC = 50 μg/mL[@bib29]*Cassine papillosa* (Hochst.) KuntzeCelastraceaeUnknownBark extracts*M. tuberculosis*MIC = 1000 μg/mL[@bib38]***Chaetachme aristata* Planch.**UlmaceaeThorny-Elm (English), basterwitpeer (Afrikaans)Leaf extracts*M. tuberculosis*MIC = 39 μg/mL[@bib21]***Chamaecrista mimosoides* (L.) Greene**FabaceaeFishbone dwarf cassia (English), boesmanstee (Afrikaans), imbubu, umbonisela (Zulu), umnyana, unobothungwana (Xhosa)Leaf and root extracts*K. pneumoniae*MIC = 2000 μg/mL (roots)[@bib72]*Cheilanthes viridis* (Forssk.) SwPteridaceaeIkhambi, lesilonda (Zulu)Leaf and stem extracts*P. aeruginosa*MIC = 460 μg/mL (leaves)[@bib36]***Chenopodium ambrosioides* L.**ChenopodiaceaeWormsalt (English), sinkingbossie (Afrikaans)Aerial parts extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]Leaf and root extracts*K. pneumoniae*MIC = 1500 μg/mL (leaves)[@bib38]*Citrus limon* (L.) OsbeckRutaceaeLemon (English)Leaf extracts*M. smegmatis* (model for TB)MIC = 2000 μg/mL[@bib87]*K. pneumoniae*MIC = 2670 μg/mL*Clausena anisata* (Willd.) Hook.f. ex Benth.RutaceaeUnknownLeaf extracts*M. smegmatis* (model for TB)MIC = 1670 μg/mL[@bib87]*K. pneumoniae*MIC = 1670 μg/mL*Clematis brachiata* Thunb.RanunculaceaeIhlonzo leziduli, inhlongo, umdloza, umfufuna (Zulu)Leaf and stem extracts*M. smegmatis* (model for TB)MIC = 2000 μg/mL[@bib87]*K. pneumoniae*MIC = 2000 μg/mL*Clematis oweniae* Harv.RanunculaceaeBridal wreath, traveller\'s joy, old man\'s beard (English), klimop, lemoenbloeisels (Afrikaans), ihlonzo leziduli, Inhlabanhlanzi (Zulu), ityolo (Xhosa), morarana-oa-mafehlo (Southern Sotho)Leaf extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib72]*Clerodendrum glabrum* E.Mey.LamiaceaeTinderwood (English), tontelhout (Afrikaans), moswaapeba (Sotho), munukha-tshilongwe (Venda), umqwaqwanam (Xhosa), umqoqonga (Zulu)Leaf, bark and root extracts*M. tuberculosis*MIC = 156 μg/mL[@bib21]Leaf extracts*K. pneumoniae*MIC = 4000 μg/mL[@bib72]*Combretum apiculatum* Sond.CombretaceaeRed bush willow (English), rooiboswilg (Afrikaans), umbondwe (Zulu), mohwelere (Pedi), muvuvha (Venda)Leaf extracts*P. aeruginosa*MIC = 1600 μg/mL[@bib24]*Combretum bracteosum* (Hochst.) Engl. & DielsCombretaceaeHiccup nut (English), hikklimop (Afrikaans), uQotha (Xhosa)Leaf extracts*P. aeruginosa*MIC = 1600 μg/mL[@bib24]*Combretum caffrum* (Eckl. & Zeyh.) KuntzeCombretaceaeEastern Cape bushwillow (English)Leaf extracts*P. aeruginosa*MIC = 6000 μg/mL[@bib24]*Combretum celastroides* Welw. ex M.A. LawsonCombretaceaeTrailing bushwillow (English)Leaf extracts*P. aeruginosa*MIC = 3000 μg/mL[@bib24]*Combretum collinum* Fresen.CombretaceaeWeeping bushwillow, bicoloured bushwillow (English), vaiërende boswilg (Afrikaans)Leaf extracts*K. pneumoniae*MIC = 315 μg/mL[@bib15]*P. aeruginosa*MIC = 555--1600 μg/mL[@bib24]; [@bib15];*Combretum edwardsii* Exell.CombretaceaeForest climbing bushwillow (English)Leaf extracts*P. aeruginosa*MIC = 3000 μg/mL[@bib24]*Combretum erythrophyllum* (Burch.) Sond.CombretaceaeRiver bushwillow (English), riviervaderlandswilg, rooiblaar, rooiblad (Afrikaans), umbondwe, umdubu-wehlandze, umhlalavane (Zulu), umdubu (Xhosa), miavana, modubo (Southern Sotho), modibo (Northern Sotho), mugavhi, mugwiti, muvuvhu (Venda)Leaf extracts*K. pneumoniae*MIC = 430 μg/mL[@bib24]; [@bib15]*P. aeruginosa*MIC = 500--3000 μg/mL*Combretum hereroense* ShinzCombretaceaeRusset bushwillow, mouse-eared combretum (English), kierieklapper (Afrikaans), mokabi (Sotho), mugavhi (Venda), umhlalavane (Zulu)Leaf extracts*P. aeruginosa*MIC = 1600 μg/mL[@bib24]*Combretum imberbe* WawraCombretaceaeLeadwood (English), hardekool (Afrikaans), motswiri (Pedi), ummono (Sotho), umbondwe omnyama (Zulu), muhiri (Venda)Leaf extracts*P. aeruginosa*MIC = 3000 μg/mL[@bib24]*Combretum kraussii* Hochst.CombretaceaeForest bushwillow (English), bosvaderlandswilg (Afrikaans), uhwabhu, umdubu-wehlathi (Zulu), ulandile (Xhosa), modlubu (Sotho), muvuvhu, muvuvhu-wannda, muvuvhu-wa-thavhani (Venda)Leaf extracts*P. aeruginosa*MIC = 1600 μg/mL[@bib24]Leaf, bark and root extracts*K. pneumoniae*MIC = 3125 μg/mL[@bib23]*Combretum microphyllum* KlotzschCombretaceaeFlame creeper (English)Leaf extracts*K. pneumoniae*MIC = 205 μg/mL[@bib15]*P. aeruginosa*MIC = 1650 μg/mL[@bib24]; [@bib15]*Combretum mkuzense* J.D.Carr & RetiefCombretaceaeMaputaland bushwillow (English)Leaf extracts*P. aeruginosa*MIC = 1600 μg/mL[@bib24]*Combretum moggii* ExellCombretaceaeRock bushwillow (English), muvuvhatavha (Venda)Leaf extracts*P. aeruginosa*MIC = 3000 μg/mL[@bib24]***Combretum molle* R.Br. ex G.Don**CombretaceaeUmbondo, umbondwe (Zulu)Leaf extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*M. smegmatis* (model for TB)MIC = 1330 μg/mL[@bib24]; [@bib87]; [@bib15]*K. pneumoniae*MIC = 550--670 μg/mL*P. aeruginosa*MIC = 800--1870 μg/mL*Combretum mossambicense* (Klotzsch) Engl.CombretaceaeKnobbly creeper (English), knoppiesklimop (Afrikaans)Leaf extracts*P. aeruginosa*MIC = 800 μg/mL[@bib24]*Combretum nelsonii* DummerCombretaceaeWaterberg bushwillow (English)Leaf extracts*P. aeruginosa*MIC = 3000 μg/mL*Combretum paniculatum* Vent.CombretaceaeBurning bush, forest flame creeper (English)Leaf extracts*P. aeruginosa*MIC = 1600 μg/mL*Combretum woodii* DummerCombretaceaeLarge-leaved forest bushwillow (English), grootblaarvaderlandswilg (Afrikaans), iWaphu (Zulu)Leaf extracts*P. aeruginosa*MIC = 800 μg/mL*Combretum padoides* Engl. & Diels.CombretaceaeThicket bushwillow (English)Leaf extracts*P. aeruginosa*MIC = 800 μg/mL*Combretum zeyheri* Sond.CombretaceaeLarge-fruited bushwillow, Zeyher\'s bushwillow (English), raasblaar, fluisterboom (Afrikaans), moduba-tshipi (Pedi), umbondwe wasembudwini (Zulu), mufhatelathundu (Venda)Leaf extracts*P. aeruginosa*MIC = 800 μg/mL*Cremaspora triflora* (Thonn.) K.Schum.RubiaceaeUnknownLeaf extracts*K. pneumoniae*MIC = 80 μg/mL[@bib22]*Croton megalobotrys* Müll.Arg.EuphorbiaceaeFeverberry (English), koorsbessie, grootkoorsbessie (Afrikaans), motsibi (Sotho), muruthu (Venda)Leaf extracts*P. aeruginosa*MIC = 313 μg/mL[@bib68]*Croton pseudopulchellus* PaxEuphorbiaceaeSmall lavender fever-berry (English), kleinlaventelkoorsbessie, sandkoorsbessie (Afrikaans), uHubeshane (Zulu)Aerial parts extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Croton silvaticus* Hochstetter ex KraussEuphorbiaceaeForest fever berry (English)Leaf extracts*P. aeruginosa*MIC = 1250 μg/mL[@bib68]*Conyza scabrida* DC.AsteraceaeOven bush (English), bakbesembossie, bakbos, oondbos (Afrikaans),Leaf extracts*M. tuberculosis*MIC = 300 μg/mL[@bib67]*K. pneumoniae*MIC = 2000 μg/mL*Cyperus articulatus* L.CyperaceaeJointed flat sedge (English)Root extracts*M. smegmatis* (model for TB)Inactive[@bib87]*K. pneumoniae*MIC = 2670 μg/mL*Cryptocarya latifolia* Sond.LauraceaeBastard stinkwood, broad-leaved laurel (English), baster-stinkhout, breëblaarkweper, breëblaar-kweper, pondo-kweper (Afrikaans), umdlangwenya, umthungwa (Zulu), umgxaleba, umgxoboth, umncatyana (Xhosa)Bark extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Datura stramonium* L.SolanaceaeJimsome weed, Devoil\'s snare (English)Leaf extracts*M. tuberculosis*MIC = 300 μg/mL[@bib67]*K. pneumoniae*MIC = 4000 μg/mL*Dioscorea dregeana* (Kunth) T.Durand & SchinzDiscoreaceaeIlabatheka (Zulu)Tuber extracts*P. aeruginosa*MIC = 390 μg/mL[@bib36]*Dioscorea sylvatica* Eckl.DiscoreaceaeIlabatheka (Zulu)Root and tuber extracts*P. aeruginosa*Inactive[@bib36]*Dioscorea sylvatica* Eckl.DiscoreaceaeForest elephant\'s foot (English)Tuber extract*M. tuberculosis*MIC = 1000 μg/mL[@bib67]*K. pneumoniae*MIC = 4000 μg/mL***Dodonaea viscosa* subsp. *angustifolia (L.f.) J.G.West***SapindaceaeSand olive (English)Leaf extracts*M. tuberculosis*MIC = 5000 μg/mL[@bib49]*M. smegmatis* (model for TB)MIC = 3125 μg/mL***Drosera capensis* L.**DroseraceaeCape sundew (English), sondouw (Afrikaans)Leaf extracts*M. tuberculosis*Inactive[@bib49]*M. smegmatis* (model for TB)MIC = 3125 μg/mLDiospyros mespiliformis Hochst. ex A.DC.EbenaceaeAfrican ebony, jackal-berry (Eng.); jakkalsbessie (Afr.); Musuma (Tshivenda); Mgula (Tsonga)Leaf hexane extract*M. tuberculosis*MIC = 100 μg/mL[@bib29]***Ekebergia capensis* Sparrm.**MeliaceaeCape ash, dogplum (English), essenhout (Afrikaans), mmidibidi (Sotho)Bark extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]Leaf extracts*M. smegmatis* (model for TB)Inactive[@bib87]*K. pneumoniae*MIC = 1330 μg/mL*Elaeodendron croceum* (Thunb.) DCCelastraceaeForest saffron (English)Leaf extracts*K. pneumoniae*MIC = 310 μg/mL[@bib22]***Eriocephalus africanus* L.**AsteraceaeWild rosemary (English), wilderoosmaryn, kapokbos (Afrikaans)Leaf extracts*M. tuberculosis*MIC = 500 μg/mL[@bib67]*K. pneumoniae*MIC = 500 μg/mL*Erythrina caffra* Thunb.FabaceaeCoast coral tree (English), kuskoraalboom (Afrikaans), umsinsi (Zulu), umsintsi (Xhosa)Root extracts*M. smegmatis* (model for TB)Inactive[@bib87]*K. pneumoniae*MIC = 8000 μg/mL*Eucalyptus grandis* W. HillMyrtaceaeRed gum, flooded gum (English)Leaf extracts*M. smegmatis* (model for TB)MIC = 2000 μg/mL[@bib87]*K. pneumoniae*MIC = 670 μg/mL***Euclea natalensis* A.DC.**EbenaceaeNatal guarri, Natal ebony, large-leaved guarri (English), Natalghwarrie, berggwarrie, swartbasboom (Afrikaans), umTshekisani, umKhasa (Xhosa), iDungamuzi, iChitamuzi, umZimane, umTshikisane, inKunzane, inKunzi-emnyama, umHlalanyamazane, umAnyathi (Zulu)Root extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Euphorbia tirucalli* L.EuphorbiaceaePencil plant, rubber-hedge euphorbia (English), kraalmelkbos (Afrikaans)Stem extracts*M. smegmatis* (model for TB)Inactive[@bib87]*K. pneumoniae*MIC = 2670 μg/mL*Faidherbia albida* (Delile) A.Chev.FabaceaeAna tree (English), anaboom (Afrikaans), mogabo (Pedi), umHlalankwazi (Zulu), muhoto (Venda)Leaf and bark extracts*K. pneumoniae*MIC = 6269 μg/mL[@bib23]***Ficus sur* Forssk**MoraceaeCape fig, broom cluster fig (English)Bark and root extracts*M. arum* (model for TB)MIC = 3130 μg/mL (bark and roots)[@bib43]*K. pneumoniae*MIC = 780--1560 μg/mL (roots)[@bib43]; [@bib23]*Flueggea virosa* (Roxb. ex Willd.) RoylePhyllanthaceaeSnowberry tree, white-berry bush (English), witbessiebos (Afrikaans), isibangamhlota sehlati, umyaweyane (Zulu)Leaf, root, bark and fruit extracts*M. tuberculosis*MIC = 312 μg/mL[@bib21]***Galenia africana* L.**AizoaceaeYellow bush (English), brakkraalbossie, geelbos, kraalbos, muisbos, muisgeelbossie, perdebos (Afrikaans), iqina (Xhosa)Bark extracts*M. tuberculosis*MIC = 1200 μg/mL (bark and roots)[@bib49]*M. smegmatis* (model for TB)MIC = 780 μg/mL (roots)*Gerrardina foliosa* Oliv.GerrardinaceaeKrantz-berry (English), Umaluleka (Zulu), Umlulama (Zulu)Aqueous bark extracts*M. tuberculosis*MIC = 310 μg/mL[@bib44]***Gunnera perpensa* L.**GunneraceaeWild rhubarb, river pumpkin (English), wilde ramenas, ravierpampoen (Afrikaans), qobo (Sotho), rambola-vhadzimu (Venda), iphuzi, ighobo (Xhosa), ugobhe (Zulu)Root extracts*M. tuberculosis*Inactive[@bib38]***Helichrysum kraussii* Sch.Bip.**AsteraceaeStraw everlasting (English), sewejaartjie (Afrikaans), isipheshane, isiqoqo (Zulu)Leaf and stem extracts*M. smegmatis* (model for TB)MIC = 2000 μg/mL[@bib87]*K. pneumoniae*MIC = 1330 μg/mL*Helichrysum melanacme* DC.AsteraceaeHotnotskooigoed (Afrikaans)Whole plant extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]***Helichrysum odoratissimum* Less.**AsteraceaeEverlantings (English), kooigoed (Afrikaans) imphepho (Zulu)Whole plant extracts*M. tuberculosis*MIC = 300--500 μg/mLMeyer, 1999; [@bib67]; Lall andWhole plant extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib67]*Heteromorpha arborescens* (Spreng.) Cham. & Schltdl.ApiaceaeParsley tree (English), wildepietersielie (Afrikaans)Leaf extracts*K. pneumoniae*MIC = 160 μg/mL[@bib22]*Heteromorpha trifoliata* (H.L.Wendl.) Eckl. & Zeyh.ApiaceaeAcetone, ethanol and aqueous leaf extracts*M. tuberculosis*MIC = 80--5000 μg/mL[@bib44]*Heteropogon contortus* (L.) P.Beauv. ex Roem. & Schult.PoaceaeTanglehead, spear grass (English), pylgras, assegaaigras (Afrikaans), isitupe (Zulu), selokana, seloka (Southern Sotho)Leaf and stem extracts*P. aeruginosa*Inactive[@bib36]*Heteropyxis natalensis* Harv.MyrtaceaeLavender tree, natal lavender (English), laventelboom (Afrikaans), inkunzi (Zulu), mudedede (Venda), inkhuzwa (Zulu).Leaf bark and root extracts*M. tuberculosis*MIC = 312 μg/mL[@bib21]*Hexalobus monopetalus* (A.Rich.) Engl. & Diels.AnnonaceaeBaboons\' breakfast, Shakama plum (English), muhodzongwa, mukorongwa, mukwingiziri, munyani, mupodzongo, mupodzongwa, musakama (Shona)Leaf, stem, root, bark and fruit extracts*M. tuberculosis*MIC = 156 μg/mL[@bib21]*Hypericum roeperianum* Schimp.ex A. Rich.HypericaceaeUnknownLeaf extracts*K. pneumoniae*MIC = 160 μg/mL[@bib22]*Hypoxis* spp.HypoxidaceaeYellow stars, star lily, african potato (English), sterretjie, Afrika-patat (Afrikaans), inkomfe, ilabatheka (Zulu)Root extracts*M. smegmatis* (model for TB)MIC = 5330 μg/mL[@bib87]*K. pneumoniae*MIC = 1670 μg/mL*Hypoxis colchicifolia* BakerBulb acetone and ethanol extracts*M. tuberculosis*MIC = 160--630 μg/mL[@bib44]Bark, acetone, aqueous and ethanol extractsMIC = 1250--2500 μg/mL*Indigofera arrecta* A.Rich.FabaceaeAfrican indigo (English)Leaf and root extracts*M. arum* (model for tuberculosis)MIC = 780 μg/mL (leafs)[@bib43]*K. pneumoniae*MIC = 390 μg/mL (roots)*Kigelia africana* (Lam.) Benth.BignoniaceaeSausage tree (English), worsboom (Afrikaans), umVunguta, umFongothi (Zulu), muvevha (Venda)Leaf and fruit extracts*K. pneumoniae*MIC = 663 μg/mL[@bib3]; [@bib14];*Krauseola mosambicina* Pax & Hoffm.CaryophyllaceaeUnknownLeaf and stem extracts*M. smegmatis* (model for TB)MIC = 1000 μg/mL[@bib87]*K. pneumoniae*MIC = 3000 μg/mL*Lantana rugosa* Thunb.VerbenaceaeBird\'s beer, bird\'s brandy (English), voëlbrandewyn, wildesalie (Afrikaans), utyani-bentaka, utywala bentaka (Xhosa), impema, ubukhwebezane, ubungungundwane, uguguvama (Zulu), mabele-mabutsoa-pele, molutoane (Southern Sotho).Leaves and stems*K. pneumoniae*MIC = 3000 μg/mL[@bib72]*Leonotis intermedia* Lindl.LamiaceaeMinaret-flower (English), klipdagga (Afrikaans), fincane, isihlungu sedobo (Xhosa), joala-ba-li-nonyana, moseneke (Southern Sotho)Leaf and stem extracts*M. arum* (model for TB)MIC = 195 μg/mL (leaves)[@bib43]*K. pneumoniae*MIC = 3130 μg/mL (leaves and stems)*Leucaena leucocephala* (Lam.) De WitFabaceaeWild tamarind, white lead tree, lead tree, koa haole, ekoa, horse tamarind, jumbie bean, white popinac (English)Leaf, bark and seed extracts*M. tuberculosis*MIC\>2500 μg/mL[@bib21]*Leucas martinicensis* (Jacq.) R.Br.LamiaceaeUnknownLeaf and flower extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib72]*Lippia javanica* (Burm.f.) SprengVerbenaceaeFever tea, lemon bush (English), koorbossie, beukesbossie, lemoenbossie (Afrikaans), inzinzinba (Xhosa), umsuzwane, umswazi (Zulu)Leaf, twig and root extracts*M. tuberculosis*MIC\>2500 μg/mL[@bib21]*M. smegmatis* (model for TB)MIC = 1000 μg/mL[@bib87]; [@bib14];*K. pneumoniae*MIC = 538 μg/mL*Maesa lanceolata* Forssk.PrimulaceaeFalse assegai (English), valsassegaai (Afrikaans), umalunguzalazikhakhona, inhlavubele, umaguqu, isidenda, ubhoqobhoqo (Zulu), intendekwane (Xhosa), muunguri (Venda)Leaf extracts*K. pneumoniae*MIC = 630 μg/mL[@bib22]*Maytenus senegalensis* (Lam.) ExcellCelastraceaeConfetti spike-thorn, confetti tree (English), rooidoring, rooi-pendoring (Afrikaans), isihlangu, Isihlangwane (Zulu), sephatwa (Sotho), tshibavhe, tshiphandwa (Venda)Aerial parts extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Morus mesozygia* StapfMoraceaeAfrican mulberry, black mulberry (English)Leaf extracts*K. pneumoniae*MIC = 80 μg/mL[@bib22]*Nidorella anomala* SteetzAsteraceaeUnknownWhole plant extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Nidorella auriculata* DC.AsteraceaeUnknownWhole plant extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Ozoroa obovata* (Oliv) R.Fern. & A.Fern.AnacardaceaeBroad-leaved resin tree (English), Breë blaarharpuisboom (Afrikaans)Leaf and bark extracts*M. smegmatis* (model for TB)MIC = 300--2000 μg/mL[@bib67]; [@bib87];*K. pneumoniae*MIC = 1000--1700 μg/mL*Parinari capensis* Harv.ChrysobalanaceaeDwarf mobola-plum, sand apple (English), bosappel, gruisappeltjie, sandappeltjie, witappeltjie (Afrikaans), mobolo-oa-fatsi (Southern Sotho)Root extracts*M. smegmatis* (model for TB)MIC = 2000 μg/mL[@bib87]*K. pneumoniae*MIC = 1500 μg/mL*Peucedanum caffrum* PhilApiaceaeUnknownRoot extracts*K. pneumoniae*MIC = 6000 μg/mL[@bib72]*Pentanisia prunelloides* (Klotzsch) Walp*.*RubiaceaeWild verbena (English), sooibrandbossie (Afrikaans), setimamollo (Sotho), icimamlilo (Zulu)Leaf and root extracts*M. arum* (model for TB)MIC = 390 μg/mL (leaves)[@bib43]*K. pneumoniae*MIC = 390 μg/mL (roots)*Pelargonium betulinum* (L.) L\'Hér. ex AitonGeraniaceaeCamphor-scented pelargonium, birch-leaved pelargonium (English), kanferblaar, maagpynbossie, suurbos (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 1000 μg/mL[@bib39]*Pelargonium citronellum* J.J.A. Van der WaltGeraniaceaeCitronella pelargonium, lemon-scented pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 3000 μg/mL[@bib39]*Pelargonium cordifolium* CurtisGeraniaceaeUnknownAerial parts extracts*K. pneumoniae*MIC = 1500 μg/mL[@bib39]*Pelargonium crispum* (P.J.Bergius) L\'Hér.GeraniaceaeLemon-scented pelargonium, crisped-leaf pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium cucullatum* (L.) L\'Hér.GeraniaceaeHooded-leaf pelargonium, (English), wildemalva (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 1500 μg/mL[@bib39]*Pelargonium fasciculaceum* E.M. MaraisGeraniaceaeUnknownLeaf extracts*K. pneumoniae*MIC = 374 μg/mL[@bib14]*Pelargonium glutinosum* (Jacq.) L\'Hér.Geraniaceaebalm-scented pelargonium, sticky-leaf pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]***Pelargonium graveolens* L\'Hér.**GeraniaceaeRose-scented pelargonium (English), wildemalva (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium greytonense* J.J.A.Van der WaltGeraniaceaeGreyton pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 3200 μg/mL[@bib39]*Pelargonium hermanniifolium* Jacq.GeraniaceaeUnknownAerial parts extracts*K. pneumoniae*MIC = 1500 μg/mL[@bib39]*Pelargonium hispidum* Willd.GeraniaceaeHispid pelargonium (English), grofharig (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium panduriforme* Eckl. & Zeyh.GeraniaceaeBalsam-scented geranium, fiddle leaf geranium (English)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium papilionaceum* (L.) L\'Hér. ex AitonGeraniaceaeButterfly pelargonium (English), rambossie (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 4000 μg/mL[@bib39]*Pelargonium pseudoglutinosum* R.KnuthGeraniaceaeUnknownAerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium quercifolium* (L.f) L\'Hér.GeraniaceaeOak-leaf pelargonium (English), muishondbos (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium radens* H.E. MooreGeraniaceaeRasp-leaved, multifid-leaved pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 2500 μg/mL[@bib39]*Pelargonium scabroide* R. KnuthGeraniaceaeUnknownAerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium scabrum* (L) L\'Hér.GeraniaceaeRough-leaved pelargonium, three-pointed pelargonium (English), hoenderbos (Afrikaans)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium sublignosum* R. KnuthGeraniaceaeUnknownAerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium tomentosum* Jacq.GeraniaceaePeppermint-scented pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib39]*Pelargonium vitifolium* (L.) L\'Hér.GeraniaceaeVine-leaved pelargonium, balm-scented pelargonium (English)Aerial parts extracts*K. pneumoniae*MIC = 4000 μg/mL[@bib39]Phymaspermum acerosum (DC.) KällersjöAsteraceaeGeelblombos (Afrikaans), isibhaha-segceke, umhlonishwa (Zulu)Acetone, ethanol and aqueous leaf extracts*M. tuberculosis*MIC = 80--630 μg/mL[@bib44]Acetone, ethanol and aqueous root extractsMIC = 40--310 μg/mL*Piper capense* L.f.PiperaceaeWild pepper (English)Root acetone extract*M. tuberculosis*MIC = −100 μg/mL[@bib29]*Pittosporum viridiflorum* SimsPittosporaceaeCheesewood, white cape beech (English), kasuur, witboekenhout (Afrikaans), umVusamvu, Umkhwenkwe, Umphushane (Zulu), kgalagangwe (Sotho), mosetlela (Southern Sotho), mulondwane, mutanzwakhamelo (Venda), umgqwengqwe (Xhosa)Leaf extracts*K. pneumoniae*MIC = 160 μg/mL[@bib22]*M. tuberculosis*MIC = −310-2500 μg/mL[@bib44]*Plectranthus neochilus* Schltr.LamiaceaeSmelly spur flower, lobster flower (English), rotstuinsalie (Afrikaans)Leaf extracts*M. smegmatis* (model for TB)MIC = 1000 μg/mL[@bib87]*K. pneumoniae*MIC = 1330 μg/mL*Podocarpus elongatus* (Aiton) L\'Hér. ex Pers.PodocarpaceaeBreede River yellowwood (English), breeriviergeelhout, westelike geelhout (Afrikaans)Leaf and stem extracts*K. pneumoniae*MIC = 1040 μg/mL[@bib1]*Podocarpus falcatus* (Thunb.) R.Br. ex Mirb.PodocarpaceaeOuteniqua yellowwood (English), Outeniekwageelhout (Afrikaans), mogôbagôba (Sotho), umsonti (Zulu)Leaf and stem extracts*K. pneumoniae*MIC = 650 μg/mL[@bib1]*Podocarpus henkelii* Stapf ex Dallim. & B.D.Jacks.PodocarpaceaeHenkel\'s yellowwood (English), Henkel-se geelhout (Afrikaans), umSonti (Zulu)Leaf and stem extracts*K. pneumoniae*MIC = 390 μg/mL[@bib1]*Podocarpus latifolius* (Thunb.) R.Br. ex Mirb.PodocarpaceaeReal yellowwood (English), opregte geelhout (Afrikaans), umkhomba (Xhosa), mogobagoba (Sotho), muhovho-hovho (Venda), umsonti (Zulu)Leaf and stem extracts*K. pneumoniae*MIC = 650 μg/mL[@bib1]***Polygala fruticosa* P.J. Bergius**PolygalaceaeButterfly bush, heart-leaf polygala (English), ertjieblom (Afrikaans), ulopesi, ulapesi, umabalabala (Xhosa), ithethe (Zulu)Leaf and root extracts*M. arum* (model for TB)MIC = 1560 μg/mL (leaves)[@bib43]*K. pneumoniae*MIC = 3130 μg/mL (roots)***Polygala myrtifolia* L.**PolygalaceaeSeptember bush (English), septemberbossie, augustusbossie, blouertjie, langelede (Afrikaans), ulopesi, ulapesi, umabalabala (Xhosa), uchwasha (Zulu)Aerial parts extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]*Pouzolzia mixta* SolmsUrticacaceaeSoap nettle (English), muthanzwa (Venda)Leaf, root and stem extracts*K. pneumoniae*MIC = 6000 μg/mL[@bib66]*Protorhus longifolia* (Bernh.) Engl.AnacardiaceaeRed beech, purple currant, red Cape beech (English), rooiboekenhout, rooimelkhout (Afrikaans), ikhubalo, isifuce (isiXhosa), umkomiso, uzintlwa (Zulu)Leaf acetone and ethanol extracts*M. tuberculosis*MIC = −160-1250 μg/mL[@bib44]*Pterocelastrus echinatus* N.E. Br.CelastraceaeHedgehog-tree, white candlewood (English), Ibholo (Xhosa), Inqayi-elibomvu (Zulu), Mutongola (Venda), Wit-kershout (Afrikaans)Bark acetone and ethanol extracts*M. tuberculosis*MIC = −160-630 μg/mL[@bib44]Leaf acetone, aqueous and ethanol extractsMIC = −160-630 μg/mL***Prunus africana* (Hook.f.) Kalkman**RosaceaeRed stinkwood, African almond (English), rooistinkhout, Afrika-amandel (Afrikaans), inyazangoma-elimnyama, inkokhokho, ngubozinyeweni, umdumezulu (Zulu), uMkakase, inyazangoma, Itywina-elikhul, Umdumizulu (Xhosa), mogohloro (Sotho), mulala-maanga (Venda)Leaf extracts*M. arum* (model for TB)Inactive[@bib43]*P. aeruginosa*MIC = 1500 μg/mL[@bib66]*K. pneumoniae*MIC = 1500--6000 μg/mL[@bib23]; [@bib66]*Psidium guajava* L.MyrtaceaeCommon guava, yellow guabva (English)Leaf extracts*M. smegmatis* (model for TB)MIC = 2000 μg/mL[@bib87]*K. pneumoniae*MIC = 670 μg/mL*Ptaeroxylon obliquum* (Thunb.) Radlk.RutaceaeSneezewood (English), nieshout (Afrikaans), umThathi (Xhosa)Leaf extracts*K. pneumoniae*MIC = 1977 μg/mL[@bib14]***Rapanea melanophloeos* (L.) Mez.**PrimulaceaeCape beech, rapanea (English), boekenhout, kaapse, boekenhout, rooiboekenhout, swartbas (Afrikaans), ikhubalwane, inhluthe, isicalabi, isiqalaba-sehlathi, umaphipha-khubalo, umhluti-wentaba, uvukwabafile (Zulu)Leaf, bark and root extracts*M. tuberculosis*MIC = 150--500 μg/mL[@bib38]; [@bib21]***Rhamnus prinoides* L\'Hér.**RhamnaceaeCamdeboo, dogwood, glossy-leaf, shiny leaf, stinkwood (English), alinkbaar, hondepishout, kamdeboo-stinkhout, seerkeelboom (Afrikaans), ulenyenye, umgilindi, umhlinye, umnyenye (Zulu)Leaf, bark, root, fruit and seed extracts*M. tuberculosis*MIC = 625 μg/mL[@bib21]*Rhoicissus tridentata* (L.f.) Wild & R.B.Drumm.VitaceaeBitter grape (English), Murumbulashedo (Venda)Root, tuber and fruit extracts*K. pneumoniae*MIC = 3000 μg/mL[@bib66]*P. aeruginosa*MIC = 3000 μg/mLLeaf acetone extract*M. tuberculosis*MIC = 50 μg/mL[@bib29]*Rhus dentate* Thunb.[Anacardiaceae](https://www.zimbabweflora.co.zw/speciesdata/family.php?family_id=10){#intref0075}Nana-berry (English), Mubikasadza (Shona)Bark acetone extract*M. tuberculosis*MIC = 50 μg/mL[@bib29]***Rumex crispus* L.**PolygonaceaeYellow dock (English)Aerial parts extracts*M. tuberculosis*Inactive[@bib38]*Salix mucronate* Thunb.SalicaceaeCape willow (English), Safsaf-wilger, kaapse wilger, wildewilgerboom (Afrikaans), munengeledzi (Venda), mogokare (Sotho), umngcunube (Xhosa), umnyezane, umzekana (Zulu)Leaf, bark and root extracts*K. pneumoniae*MIC = 6250 μg/mL[@bib23]*Sansevieria hyacinthoides* (L.) DruceAsparagaceaeMother-in-law\'s tongue, piles root, bowstring hemp (English), skoonma-se-tong, aambeiwortel, haasoor (Afrikaans), kai, ghaiwortel (Khoi), isikholokotho (Xhosa, Zulu), isikwendle, isitokotoko (Zulu)Leaf extracts*M. smegmatis* (model for TB)Inactive[@bib87]*K. pneumoniae*MIC = 4000 μg/mL*Scadoxus puniceus* (L.) Friis & NordalAmaryllidaceaePaintbrush lily, snake lily (English), rooikwas (Afrikaans), isisphompho, umgola (Zulu)Leaf extracts*M. smegmatis* (model for TB)MIC = 2670 μg/mL[@bib87]*K. pneumoniae*MIC = 3000 μg/mL*Schkuhria pinnata* (Lam.) Kuntze ex Thell.CompositaeDwarf marigold (English)Leaf extracts*K. pneumoniae*MIC = 3000 μg/mL[@bib72]*P. aeruginosa*MIC = 270 μg/mLKudumela et al., 2018*M. smegmatis*MIC = 270 μg/mL[@bib47]; [@bib48].*Schotia brachypetala* Sond.FabaceaeWeeping boer-bean, tree fuchsia, African walnut (English), huilboerboon (Afrikaans) umfofofo (Xhosa), uvovovo (Zulu), molope (Northern Sotho), mutanswa (Venda), nwavilombe (Tsonga); umutwa (Tswana), uvovovo (Swati)Bark acetone extracts*M. tuberculosis*MIC = 50 μg/mL[@bib29]*Sclerocarya birrea* (A. Rich.) Hochst.AnacardaceaeMarula (English), morula (Northern Sotho)Bark extracts*M. smegmatis* (model for TB)MIC = 1330 μg/mL[@bib87]*K. pneumoniae*MIC = 670 μg/mL***Securidaca longipedunculata* Fresen.**PolygonaceaeViolet tree (English), krinkhout, rooipeultjie, seepbasboom (Afrikaans), mpesu (Venda), iphuphuma (Zulu)Roots*Haemophilus influenzae*Inactive[@bib62]*Senecio deltoideus* Less.AsteraceaeCanary creeper (English), undenze (Xhosa)Leaf extracts*Mycobacterium smegmatis* (model for TB)MIC = 1330 μg/mL[@bib87]*K. pneumoniae*MIC = 1330 μg/mL***Senecio serratuloide*s DC.**AsteraceaeTwo-day cure (English), ichazampukane, insukumbili, umaphozisa umkhuthelo (Zulu)Aerial parts extracts*M. tuberculosis*MIC = 5000 μg/mL[@bib38]Leaf extracts*M. smegmatis* (model for TB)MIC = 1330 μg/mL[@bib87]*K. pneumoniae*MIC = 1330 μg/mL*Siphonochilus aethiopicus* (Schweinf.) B.L. BurttZingiberaceaeNatal ginger, wild ginger (English), wildegemmer (Afrikaans), indungulo, isiphephetho (Zulu)Root extracts*M. tuberculosis*MIC = 300 μg/mL[@bib67]*K. pneumoniae*MIC = 4000 μg/mL***Syzygium cordatum* Hochst. ex Krauss**MyrtaceaeWaterberry (English), waterbessie, waterboom (Afrikaans), undoni (Zulu), umswi, umjomi (Xhosa), mawthoo (Southern Sotho), motlho (Northern Sotho), mutu (Venda)Bark extracts*H. influenzae*MIC = 1000 μg/mL[@bib62]*M. tuberculosis*MIC = 300 μgmL[@bib67]*M. smegmatis* (model for TB)MIC = 1330 μg/mL[@bib87]*P. aeruginosa*MIC = 310 μg/mL[@bib66]*K. pneumoniae*MIC = 300--2000 μg/mL[@bib14]; [@bib87]; [@bib66]; [@bib67]***Tabernaemontana elegans* Stapf**ApocynaceaeToad tree (English),laeveldse paddaboom (Afrikaans), umKhahlwana, umKhadu (Zulu)Leaves, roots, rhizome, sap*M. tuberculosis*MIC = 1250 μg/mL[@bib21]*H. influenzae*Inactive[@bib62]***Terminalia phanerophlebia* Engl. & Diels**CombretaceaeLebombo cluster-leaf (English), lebombotrosblaar (Afrikaans), amaNgwe-amnyama, amaNgwe-omphofu (Zulu)Leaf, root and twig extracts*M. arum* (model for TB)MIC = 195 μg/mL (leaves and twigs)[@bib43]*K. pneumoniae*MIC = 195 μg/mL (twigs)*Terminalia pruinoide*s M.A.LawsonCombretaceaePurple-pod terminalia (English), deurmekaar, sterkbos (Afrikaans)Leaf extracts*K. pneumoniae*MIC = 432 μg/mL[@bib14]; [@bib15]; [@bib24]*P. aeruginosa*MIC = 360--1600 μg/mL***Terminalia sericea* Burch. ex DC.**CombretaceaeSilver cluster leaf (English), vaalboom (Afrikaans), mususu (Venda)Bark, root and leaf extracts*M. smegmatis* (model for TB)MIC = 670 μg/mL[@bib87]*K. pneumoniae*MIC = 250--670 μg/mL[@bib87]; [@bib72]; [@bib14]*P. aeruginosa*MIC = 6000 μg/mL[@bib24]Bark acetone extract*M. tuberculosis*MIC = 25 μg/mL[@bib29]***Tetradenia riparia* (Hochst.) Codd**LamiaceaeMisty plume bush, ginger bush (English), gemerbos, watersalie (Afrikaans), iboza, ibozane (Zulu)Root extracts*M. tuberculosis*MIC = 300 μg/mL[@bib67]Leaf extracts*M. smegmatis* (model for TB)MIC = 1000 μg/mL[@bib87]*K. pneumoniae*MIC = 1750 μg/mL***Thymus vulgaris* L.**LamiaceaeGerman thyme, common thyme (English)Aerial parts extracts*M. tuberculosis*MIC = 500 μg/mL[@bib38]***Trema orientalis* (L.) Blume**CannabaceaePigeonwood (English), hophout (Afrikaans), ifamu, iphubane, isakasaka, isikhwelamfene, sakasaka, ubathini, umbengele, umbhangabhanga, umdindwa, umsekeseke, umvangazi (Zulu)Leaves, stems, roots, bark, fruit, twigs and seeds*M. tuberculosis*MIC = 312 μg/mL[@bib21]*Trichilia dregeana* Sond.MeliaceaeForest mahogany, Cape mahogany, red ash (English), rooiessenhout, bosrooiessenhout, basteressenhout (Afrikaans), umKhuhlu, uMathunzini (Zulu), umKhuhlu (Xhosa), mmaba (Sotho), mutuhu, mutshikili (Venda)Leaf, bark and root extracts*K. pneumoniae*MIC = 6250 μg/mL[@bib23]***Trichilia emetica* Vahl**MeliaceaeNatal mahogany (English), rooiessenhout (Afrikaans), mamba (Sotho), umathunzini (Zulu), umkhuhlu (Xhosa), mutuhu (Venda)Leaf extracts*M. smegmatis* (model for TB)MIC = 2670 μg/mL[@bib87]*K. pneumoniae*MIC = 1670 μg/mL***Tulbaghia violacea* Harv.**AmaryllidaceaeWild garlic (English), wilde knoffel (Afrikaans), isihaqa (Zulu)Root and leaf extracts*M. arum* (model for TB)MIC = 780 μg/mL[@bib7]*K. pneumoniae*MIC = 277 μg/mL[@bib14]*Vernonia colorata* (Willd.) DrakeAsteraceaeEnglish bitter leaf, bitters tree (English)Leaf, stems and root extracts*P. aeruginosa*MIC = 520 μg/mL (leaves)[@bib36]*Vitex rehmannii* GürkeLamiaceaePipe-stem fingerleaf (English), umluthu (Zulu), munyongatshifumbu (Venda)Leaf extracts*K. pneumoniae*MIC = 2000 μg/mL[@bib72]***Warburgia salutaris* (G.Bertol.) Chiov.**CanellaceaePepper-bark tree (English), peperbasboom (Afrikaans), mulanga, manaka (Venda), isibhaha (Zulu)Bark and leaf extracts*M. tuberculosis*MIC = 156 μg/mL[@bib21]*K. pneumoniae*MIC = 624 μg/mL[@bib14]Leaf acetone extracts*M. tuberculosis*MIC = 25 μg/mL[@bib29]*Xerophyta retinervis* BakerVelloziaceaeBlack-stick lily (English), besembos, bobbejaanstert (Afrikaans), isigqumana, isiphmba (Zulu)Bark extracts*M. tuberculosis*MIC = 300 μg/mL[@bib67]*K. pneumoniae*MIC = 500 μg/mL*Ximenia caffra* Sond.OlacaceaeSour plum (English), mutshili (Venda)Leaf and root extracts*K. pneumoniae*MIC = 3000 μg/mL[@bib66]*P. aeruginosa*MIC = 6000 μg/mL[@bib66]*Zanthoxylum davyi* Waterm.RutaceaeForest knobwood (English)Root and bark extracts*K. pneumoniae*MIC = 2000 μg/mL (bark)[@bib72]*Zornia milneana* Mohlenbr.FabaceaeLukandulula (Venda)Whole plant extracts*K. pneumoniae*MIC = 3000 μg/mL[@bib66]*P. aeruginosa*MIC = 3000 μg/mL***Ziziphus mucronata* Willd.**RhamnaceaeBuffalo thorn (English), blinkblaar-wag-\'n-bietjie (Afrikaans), umphafa, umlahlankosi, isilahla (Zulu), umphafa (Xhosa), mutshetshete (Venda), mokgalô, moonaona (Sotho)Bark extracts*M. smegmatis* (model for TB)Inactive[@bib49]Leaf, bark and root extracts*M. tuberculosis*MIC = 156 μg/mL[@bib21]*K. pneumoniae*MIC = 4000 μg/mL[@bib72]Bark extract*M. tuberculosis*MIC = 50 μg/mL[@bib29][^1]

Several trends regarding the plant part used traditionally were also apparent. The use of leaves was particularly common for the treatment of bacterial respiratory infections, with the use of leaves recorded for 68 southern African plant species ([Fig. 2](#fig2){ref-type="fig"} ). Interestingly, leaves are also the most frequently used plant part for the treatment of many other pathogenic diseases ([@bib2]; [@bib4]; [@bib13]; [@bib12]; [@bib18]; [@bib33], 2017; [@bib65]). The roots of 58 plant species were also used to treat several bacterial respiratory diseases, whilst bark (15 species) and stems and twigs (10 species) were also relatively widely used. In contrast flowers, fruit and seeds were only rarely used to treat bacterial respiratory disease. In contrast, the whole plant of some species was used therapeutically in southern African traditional medicine. Complete ethnobotanical records were not available for 36 plant species and we were therefore not able to determine the part used traditionally to treat bacterial respiratory diseases.Fig. 2Frequency of use of different southern African plant parts to treat bacterial respiratory infections.Fig. 2

4.2. Scientific studies into the growth inhibitory activity of South African plants against bacterial respiratory pathogens {#sec4.2}
---------------------------------------------------------------------------------------------------------------------------

Whilst the ethnobotanical usage of many southern African plants to treat bacterial respiratory infections are yet to be scientifically evaluated, 189 southern African plant species have been screened for the ability to inhibit the growth of bacterial respiratory infections ([Table 2](#tbl2){ref-type="table"}). Interestingly, only 42 species (indicated in bold within [Table 2](#tbl2){ref-type="table"}) (of the 186 species that are used in traditional medicine to treat bacterial respiratory diseases have been tested against one or more bacterial respiratory pathogens. This equates to approximately only 23% of the species traditionally used to treat bacterial respiratory diseases. The remaining 77% are yet to be evaluated against any of the respiratory pathogens. Furthermore, the majority of the plants species that have been screened have only been tested against a single bacterial respiratory pathogen and further studies are required to test them against other bacterial species and strains.

The vast majority of plants that have been tested against pneumonia-causing bacterial pathogens have been screened against *K. pneumoniae* and *P. aeruginosa*. Indeed, 139 plant species were tested against one or both of these pathogens. Eighty-nine plant species were also screened against *M. tuberculosis*, or other *Mycobacterium* spp. (*M. arum* and *M. smegmatis*) as TB model organisms. Furthermore, many of these species were screened against both the TB and pneumonia-causing bacteria. The high numbers of plants screened against these pathogens may be due to the serious consequences of contracting TB or pneumonia, both of which may result in mortality.

The high numbers of plants screened against the pneumonia-causing bacteria may also result from these bacteria also being implicated in several other illnesses. Often, when plant extracts are screened against these bacteria, the testing was targeting those other diseases. For example, several of the southern African plants screened against *K. pneumoniae* (*Agathosma betulina* (Berg.) Pillans, *Ballota africana* Benth., *Carpobrotus edulis* (L.) N.E. Br, *Combretum collinum* Fresen., *Combretum erythrophyllum* (Burch.) Sond., *Combretum microphyllum* Klotzsch, *Combretum molle* R.Br., *Kigellia africana* (Lam.) Benth., *Lippia javanica* (Burm F.) Spreng, *Pelargonium fasiculata* Colvill ex Sweet, *Ptaeroxylon obliquum* (Thunb.) Radlk., *Syzygiuym cordatum* (Hochst.), *Terminalia pruinoides* Lawson, *Terminalia Sericea* Burch. ex DC., *Tulbaghia violacea* Harv., *Warburgia salutaris* (Bertol.f.) Chiov.) were tested in studies focused on the trigger mechanisms of the autoimmune disease ankylosing spondylitis ([@bib3]; [@bib16], 2015; [@bib16], 2014). Despite the different focus, these studies also evaluate the use of the plants for the treatment of bacterial pneumonia.

Due to the important pathogenesis of TB in Southern Africa, a relatively large number of southern African plant species have already been screened for anti-*M. tuberculosis* activity ([@bib29]; [@bib21]; [@bib44]). However, the majority of plants identified as being used to treat TB are yet to be tested, and substantially more work is required in this field.

Other bacterial pathogens associated with respiratory diseases have been poorly studied with respect to validation and southern African medicinal plant use. Indeed, only four plants species were screened against *Haemophilus influenzae* (*Asparagus falcatus* (L.) Oberm., *S. longpedunculata*, *S. cordatum, T. elgans*) and we were unable to find any studies that screened southern African plants against *C. diptheriae* or *B. pertussis* (the causes of diphtheria and whooping cough respectively). These diseases all cause considerable distress. However, effective vaccines against *C. diptheriae* or *B. pertussis* are available, and their use is now routine. Therefore, cures for these diseases are considered of lower priority, possibly accounting for the lack of screening against these pathogens. However, these vaccines are only effective as preventatives and are of little use if a pathogen infection occurs. Furthermore, neither vaccination nor prior exposure to *C. diptheriae* or *B. pertussis* confer lifelong immunity and a vaccinated individual may still contract the disease several years after initial vaccination. Therefore, regular 'booster' vaccinations are required to prevent these diseases. Cures are still required to overcome the illness once infection with these bacteria occurs, and treatments for these diseases should not be neglected.

A critical analysis of the plant species studied in [Table 2](#tbl2){ref-type="table"} demonstrates that 75% do not demonstrate noteworthy activities. It has been recommended ([@bib75]), that efficacies ≤ 160 μg/mL should only be considered as noteworthy. One does, however, need to take cognisance that each study may not have been tested against all known respiratory pathogens and as such, the plant species while not demonstrating efficacy against a particular tested bacterial strain, may prove to be more active against other bacterial strains not included in the pathogen set. Some plant species demonstrating noteworthy efficacy against *M. tuberculosis* include *B. discolour* (10.5--12.5 μg/mL), *B. micrantha* (25 μg/mL), *C. petersiana* (50 μg/mL), *D. mespiliformis* (100 μg/mL) ([@bib29]), as well as *C. aristate* (39 μg/mL), *C. glabrum* (156 μg/mL) and *H. monopetalus* (156 μg/mL) ([@bib21]). Other plant species also demonstrating noteworthy activity against *M. tuberculosis* were *P. acerosum, P. capense*, *P. longifolia, P. echinatus, R. melanophloeos. R. tridentate, R. dentate, S. brachypetala, T. sericea, W. salutaris* and *Z. mucronata* ([@bib29]; [@bib21]; [@bib44]). Other plant species such as *C. aurea* and *C. triflora* demonstrated noteworthy efficacy against *K. pneumoniae* at 80 μg/mL ([@bib22]). Other plant species demonstrating noteworthy activity against *K. pneumoniae* include *Heteromorpha* spp., *H. roeperianum, H. colchicifolia, M. mesozygia, P. viridiflorum* ([@bib22]; [@bib44]). What is even more interesting is the fact that only four plant species (*C. aristata T. sericea, W. salutaris* and *Z. mucronate*) were affiliated to traditional use ([Table 1](#tbl1){ref-type="table"}). Furthermore, only two bacterial species (*M. tuberculosis* and *K. pneumoniae*) correlated with noteworthy activity.

All the investigations that screened southern African plants against bacterial respiratory diseases used *in vitro* methods and none of the plant preparationshave been evaluated *in vivo*. This is may be due to ethical concerns and the understandable global trend to replace *in vivo* test models (where possible) with *in vitro* testing. However, whilst the *in vitro* properties may be promising and indicate further evaluation is required, many other pharmacodynamic and pharmacokinetic factors also affect the safety and efficacy of all chemotherapies. Where promising activity is detected, fuerther *in vivo* studies are required to evaluate the suitability of these plants for therapeutic use.

There are no records of ethnobotanical use to treat bacterial respiratory diseases for the other majority plant species that have been screened against bacterial respiratory pathogens. Indeed, 212 of the 254 plant species that have been already screened (approximately 83%) were selected for study for reason other than ethnobotanical usage. Those plant species were selected based on alternative criteria, including the investigators bias for a specific genus/family. For example, 21 *Combretum* species and three *Terminalia* species have been screened against bacterial respiratory pathogens ([@bib14]; [@bib15]; [@bib43]; [@bib87]; [@bib23]; [@bib24]; [@bib38]) despite only two *Combretum* species and two *Terminalia* species being traditionally used for that purpose. The selection of the *Combretum* and *Terminalia* species correlates with the research background of specific researchers where interest in the plant family Combretaceae, was the focus. Plant species from the family Combretaceae from other regions of the world have demonstrated similar interesting activities ([@bib11]; [@bib40]; [@bib24]) and therefore these species are good candidates for testing.

5. Discussion {#sec5}
=============

Traditional herbal medicines are promising sources of potential new antibacterial chemotherapeutics. In many cases, their use has been documented for hundreds (or even thousands of years), aiding in species selection for study. Southern African traditional plant use has particularly good potential as there are high biodiversity levels and relatively good records of plant use. Through extensive review of the available ethnobotanical literature, we identified 187 plant species that are used in one or more southern African healing systems to treat either TB, diphtheria, pertussis or bacterial pneumonia. Surprisingly given the ease of transmission and severity of these diseases, only 42 of the identified species have been screened against bacterial causes of these diseases. All of those species were reported to be effective against one or more bacterial respiratory pathogens. However, the other 145 species identified as traditional treatments for respiratory diseases of bacterial origin remain to be screened.

Even when a plant species has been screened against a bacterial respiratory pathogen, they were usually only tested against one or two pathogens. The plants have been most extensively tested against TB and pneumonia causing pathogens, because of the ease of transmission and relatively high mortality rates caused by these diseases. However, with a few notable exceptions, those studies screen against bacterial strains that are also susceptible to other conventional antibiotics. Given the high incidence of multiple drug resistant strains of *M. tuberculosis* (\~92% in southern Africa; [@bib81]) and of some pneumonia causing bacteria, testing against resistant strains of these bacteria is important to develop new therapies. Ideally, any new therapies targeting those pathogens should function via different mechanisms to the existing drugs so that they may also be effective in resistant bacterial strains. Thus, where a plant-based therapy has demonstrated efficacy towards one or more bacterial respiratory pathogens, follow-up studies should also test the preparations against resistant and neglected strains.

In comparison to TB and bacterial pneumonia, studies screening plant extracts against *C. diphtheriae* and *B. pertussis* are lacking. Indeed, we were unable to find any studies screening southern African plants against these bacteria. To an extent, this is understandable, particularly for *C. diphtheriae.* Highly efficient vaccines are available against this pathogen and the rates of new diphtheria infections in particular have decreased dramatically and there are now only approximately 4500 new infections reported annually worldwide ([@bib82]). However, when an individual is infected with *C. diptheriae*, there is a 5--10% mortality rate. The incidence of pertussis has also declined substantially since the introduction of widespread vaccination programs, with the levels of infection decreased to 150,000 new cases in 2018, with nearly 90,000 deaths ([@bib83]). These rates are still concerning and studies seeking new cures for these diseases should not be ignored, particularly given the rapid emergence of antibiotic resistant strains of *C. diphtheriae* and *B. pertussis* in recent years.

Notably, all of the screening studies have only used *in vitro* models to screen the traditional medicines. We were unable to find any studies that screened the plants in *in vivo* systems. *In vitro* modelling is best regarded as an initial step in the developing of new drugs from natural sources. Activity in an *in vitro* system may not necessarily translate to activity *in vivo*. A large number of bioavailability issues will influence the activity of a plant preparation *in vivo.* Where promising activity is detected *in vitro*, the plant preparations should be re-screened using an appropriate *in vivo* model organism. Furthermore, pharmacodynamics and pharmacokinetic parameters should be examined so that appropriate doses and treatment regimens can be modelled.

Of the plants that have been screened for inhibitory activity against the bacterial respiratory pathogens, few were also tested for toxicity. These plants have often been used therapeutically for hundreds of years and it is possible that researchers assume that they are safe and have therefore not focused on the toxicological aspects of the traditional medicine. Many of these plants have been screened for toxicity in other studies ([@bib25]; [@bib71]). However, the focus of those studies was solely on evaluation of toxicity of the extracts, or on investigating the safety of the extracts in conjunction with different bioactivities. Toxicological screening studies should be performed in parallel with therapeutic screening studies to allow the safety index to also be reported. Differences in the methods used to process the plants, as well as differences between collection locations, seasons of collection etc. may result in substantial differences between phytochemical profiles of the different preparations. This may significantly alter their toxicity profiles of the different preparations. It may therefore not be valid to assume that the toxicity profile reported in one study also indicates that bioactive extracts in another study will also be safe. Instead, toxicity evaluations and bioactive screening studies should be included in the same report. Furthermore, to allow for comparisons between different studies, toxicity evaluations should ideally incorporate more than one toxicity model.

6. Conclusions {#sec6}
==============

In conclusion, despite ethnobotanical records of a substantial number of southern African plant species used to treat bacterial respiratory diseases, many are yet to be tested for inhibitory activity against any repiratory bacterial pathogen and substantially more work is need in this field. Indeed, one One hundred and eighty-seven southern African plant species are recorded as traditional therapies for bacterial respiratory infections. Scientific evaluations of 178 plant species were recorded. Of the species evaluated for therapeutic properties, only 42 species were selected for screening on the basis of their ethnobotanical uses. Therefore, the potential of 146 species used teraditionally to treat bacterial respiratory diseases are yet to be verified. Furthermore, the species that have been tested against some bacterial respiratory pathogens generally have only been tested against one a few bacteria respiratory pathogens and testing against other bacteria is required. Furthermore, most plant species have only been tested against antibiotic-sensitive pathogen strains. Given the rapid development of antibiotic resistance, the southern African plant species identified in our study should also be screened against antibiotic resistant bacterial strains.

Whilst substantial effort is required to screen southern African plants against respiratory bacterial pathogens, a directed approach is recommended. Plant preparations should initially be screened against the pathogens for which they were traditionally used. Furthermore, testing against the pathogens that cause the more serious respiratory diseases (tuberculosis, bacterial pneumonia) is recommended to decrease the burden caused by these diseases. Diphtheria and pertussis are less of a concern than tuberculosis and pneumonia due to the development of effective vaccines against those pathogens. However, they also should not be neglected as the bacteria responsible for these diseases are increasingly evading the vaccines and are concurrently developing resistance to clinical antibiotics. It is hoped that this review will highlight promising species for testing, which may aid in the development of new therapies against bacterial respiratory diseases.

Appendix A. Supplementary data {#appsec1}
==============================

The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1
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[^1]: Where multiple solvent extractions and/or multiple plant parts were tested for a plant species, the MIC values reported here were for the most active extract (as judged by MIC value). Plant species indicated in bold are species documented ethnobotanically ([Table 1](#tbl1){ref-type="table"}).
